Thermal Therapy in Space Medicine: NASA Research on Heat and Cold for Astronaut Health

Introduction: The Extreme Environment Laboratory of Space Medicine

Space is the most extreme physiological laboratory available to science. The microgravity environment, cosmic radiation exposure, psychological isolation, altered sleep cycles, and radical temperature extremes of space missions compress decades of normal human physiological aging into months of spaceflight. Every system of the human body responds to spaceflight in ways that parallel, and often exceed, the pathological changes seen in the most severely deconditioned patients on Earth.

This compression of physiological challenge makes space medicine one of the most information-dense fields in all of biomedical research. When NASA scientists discover a countermeasure that protects astronaut cardiovascular function during a six-month International Space Station mission, they are simultaneously developing insights applicable to bed-ridden hospital patients, aging adults with sedentary lifestyles, and athletes recovering from injuries. The biological mechanisms are identical because the underlying physiological derangements, fluid shift, muscle atrophy, bone resorption, immune dysfunction, and cardiovascular deconditioning, share common molecular pathways whether caused by zero gravity or prolonged inactivity on Earth.

Within this context, thermal therapy occupies a uniquely interesting position in space medicine research. Heat and cold have been used for human health since the earliest recorded medical practices. But their application in the space environment introduces engineering and physiological challenges that have driven NASA and the European Space Agency (ESA) to develop highly sophisticated protocols and hardware. The research generated by these space-specific challenges has produced insights about thermal physiology that would not have emerged from conventional Earth-based research alone.

This article traces the arc of thermal therapy research in space medicine from its early origins in cardiovascular deconditioning countermeasures through the current state of research programs active on the International Space Station and in ground-based bed rest analog studies. The goal is not only to explore the science of thermal therapy in extreme environments but to extract the practical lessons that inform optimal thermal therapy practice for people using saunas and cold plunges on Earth today.

Understanding why NASA scientists are deeply interested in heat therapy's cardiovascular effects, cold therapy's muscle preservation potential, and thermal cycling's immune-modulating properties provides a completely different frame for understanding why your daily sauna or cold plunge practice produces the physiological benefits it does. Space medicine has conducted the most rigorous research on cardiovascular deconditioning, and its findings underpin some of the strongest evidence for heat therapy's cardiovascular benefits in the civilian population.

The stakes in space medicine countermeasure research are also uniquely high. An astronaut who experiences cardiovascular collapse during planetary landing after months in microgravity cannot simply rest and recover. A crew member with severe muscle atrophy cannot perform an emergency spacewalk. These operational imperatives have driven the development of countermeasure protocols that are maximally effective, feasible in constrained spacecraft environments, and compatible with other mission demands. The rigor born of these operational necessities has produced research of exceptional quality, with implications that extend far beyond the specific context of human spaceflight.

The science of sauna and thermal therapy on Earth owes a substantial intellectual debt to space medicine research, a connection that is rarely acknowledged in popular wellness literature but is central to understanding why the cardiovascular and physiological benefits of regular heat and cold therapy are as strong as they are.

Cardiovascular Deconditioning in Microgravity: The Problem Thermal Therapy Addresses

Cardiovascular deconditioning is the most clinically significant and extensively studied consequence of space travel. In Earth's gravitational field, approximately 70% of total blood volume is located below the heart, maintained there by gravity. The cardiovascular system pumps blood upward against gravity to supply the brain and upper body. The muscles of the lower extremities assist venous return through muscular pumping action during ambulation. This gravitational pressure gradient is a constant challenge that also constitutes a training stimulus maintaining cardiovascular architecture.

Upon entering microgravity, the hydrostatic pressure gradient disappears instantly. Blood redistributes from the lower extremities to the thorax and head, producing a fluid shift of approximately 1 to 2 liters of blood volume. The cardiovascular system interprets this central fluid surplus as volume excess and initiates a diuresis that reduces total blood volume by 10 to 15% within the first few days of spaceflight. This is a perfectly logical physiological adaptation to the perceived fluid excess, but it sets the stage for profound cardiovascular deterioration when the astronaut returns to Earth's gravity.

After six months on the International Space Station, astronauts show left ventricular mass reductions of 10 to 15% due to the reduced pressure load on the heart. Stroke volume decreases by 15 to 25%. VO2max typically declines by 20 to 25% despite regular exercise countermeasures. Orthostatic tolerance, the ability to maintain blood pressure in an upright posture, is severely compromised, with a significant proportion of returning astronauts experiencing orthostatic hypotension or syncope upon return to Earth's gravity. These changes collectively constitute what space medicine terms "cardiovascular deconditioning," and they represent a model for the cardiovascular deterioration associated with aging, bed rest, and sedentary lifestyles on Earth.

Research by Charles Hargens at the University of California San Diego, who has spent four decades on the problem of spaceflight-induced cardiovascular deconditioning, has established several key insights about the mechanisms of deconditioning and the countermeasures most effective for preventing it. His work and that of collaborators at NASA's Johnson Space Center has identified cardiovascular preload reduction, the loss of venous return from the lower extremities without gravitational assistance, as the central deranging mechanism. Any countermeasure that restores cardiovascular preload or simulates the loading conditions of gravity on Earth becomes therapeutically relevant.

This is precisely where thermal therapy enters the picture. Heat therapy, specifically whole-body heating that produces the sustained peripheral vasodilation and thermal cardiovascular stress of a sauna session, creates a cardiovascular demand that in several key respects mimics the demands of upright posture and physical activity. The cardiovascular system must pump blood to an expanded peripheral vascular bed, increase cardiac output, and maintain blood pressure in the face of decreased peripheral vascular resistance, all of which are cardiovascular challenges that preserve cardiac muscle and maintain orthostatic tolerance mechanisms.

The Bed Rest Model: Earth's Best Analog for Microgravity

Because conducting cardiovascular research in actual microgravity is expensive, logistically complex, and limited in study population size, space medicine researchers rely heavily on head-down tilt bed rest (HDTBR) as a ground-based analog. In HDTBR studies, subjects lie in a bed tilted 6 degrees head-down for periods ranging from a few days to 60 or 90 days, while researchers measure the same physiological changes that occur in microgravity. The fluid shift, blood volume reduction, cardiovascular deconditioning, and muscle atrophy of HDTBR closely parallel those of actual spaceflight, making it a validated research platform for testing countermeasures that would then be applied in actual space missions.

The most extensive thermal therapy countermeasure research has been conducted in HDTBR settings, where subjects can be randomized, controlled, and repeatedly measured with precision that is impossible on the ISS. Research at the Institute for Biomedical Problems in Moscow, which has operated the world's longest-running HDTBR program, has tested heat therapy protocols in HDTBR subjects with results that have directly informed ISS countermeasure protocols.

Thermoregulation in Microgravity: How Space Changes Body Temperature Control

The human thermoregulatory system depends on convective heat exchange, the ability to transfer body heat to the surrounding air or water through fluid movement, as its primary mechanism for body temperature maintenance during exercise. In microgravity, convective heat exchange is severely disrupted because the absence of gravity prevents the natural convection currents that move warm air away from the body's surface. Without natural convection, a layer of warm, moist air forms around an astronaut's body during any physical exertion, creating a natural insulating layer that impairs heat dissipation and leads to core temperature rise more rapidly than on Earth.

Research by Victor Convertino at the US Army Institute of Surgical Research, and complementary work by Roger Leach at the Institute of Aviation Medicine, has characterized the thermoregulatory impairment of spaceflight in detail. Astronauts exercising on the ISS reach higher core temperatures for equivalent exercise intensities than they would for the same exercise on Earth. Sweat rate increases as compensation, but the sweated fluid pools near the body without evaporation-enhancing convective airflow, reducing evaporative cooling efficiency. Without carefully engineered airflow systems, astronauts would be at risk of dangerous hyperthermia during even moderate exercise.

This altered thermoregulation has direct implications for understanding how the body responds to deliberate thermal therapy interventions. The cardiovascular and hormonal responses to heat stress are mediated partly by peripheral thermoreceptors sensing skin temperature and partly by central thermoreceptors sensing core temperature. In microgravity, the relationship between exercise intensity, skin temperature, and core temperature is different from on Earth, meaning that thermal stress thresholds for cardiovascular adaptation may also differ. This insight has driven research into thermal therapy protocols specifically calibrated for the microgravity thermoregulatory context.

Cold exposure in space presents different but equally significant challenges. The outer hull of the ISS can reach temperatures as low as minus 150 degrees Celsius in shadow and above 120 degrees Celsius in direct sunlight. Inside the pressurized cabin, temperatures are maintained within habitable ranges by active thermal control systems. But the body's cold-adaptive mechanisms are tested in the context of EVA (extravehicular activity, or spacewalking), where spacesuit thermal management must counteract both the extreme external thermal environment and the metabolic heat generated by the astronaut's physical exertion during the EVA.

Cold adaptation research in space medicine focuses primarily on understanding how the loss of normal gravitational fluid distribution affects cold tolerance and cold-induced cardiovascular responses. Research from multiple ISS missions has found that astronauts show altered sympathetic responses to cold stimuli compared to pre-flight baselines, with the magnitude and pattern of norepinephrine release changed by the spaceflight environment in ways that are still being characterized. This finding has important implications for understanding cold immersion therapy on Earth, as it suggests that gravitational fluid distribution is a modulator of the catecholamine response to cold, independent of the cold stimulus itself.

NASA LBNP Protocols: Lower Body Negative Pressure as Heat Analog

Lower body negative pressure (LBNP) is one of NASA's most extensively studied cardiovascular countermeasures for spaceflight. LBNP devices create a partial vacuum around the lower body, drawing blood downward from the thorax into the legs in a simulation of the gravitational fluid distribution that exists on Earth. By partially restoring the normal gravitational blood distribution pattern, LBNP maintains cardiovascular preload, preserves orthostatic tolerance, and provides a cardiovascular stress stimulus that counteracts the effects of microgravity-induced cardiac deconditioning.

LBNP and heat therapy share a common cardiovascular mechanism: both reduce central venous return and challenge the cardiovascular system to maintain cardiac output under reduced preload conditions. In a sauna, peripheral vasodilation moves blood away from the central venous pool to the peripheral vasculature, reducing cardiac preload and requiring increased heart rate and maintained stroke volume to preserve cardiac output. In LBNP, the negative pressure gradient draws blood into the lower extremities, achieving a similar reduction in cardiac preload through a different physical mechanism.

Research, comparing the physiological effects of LBNP and heat therapy in HDTBR subjects, found significant overlap in cardiovascular responses. Both interventions increased heart rate, reduced stroke volume per beat, maintained cardiac output through increased heart rate compensation, and stimulated baroreceptor-mediated sympathetic activation. The researchers concluded that heat therapy could serve as a partial functional analog to LBNP for cardiovascular countermeasure purposes, with the practical advantage that heat therapy requires simpler hardware, has no significant adverse effects at appropriate doses, and may produce additional metabolic and anti-inflammatory benefits beyond the cardiovascular preload challenge.

This finding was published in the Journal of Applied Physiology and subsequently influenced the development of heat therapy protocols in both the space medicine and clinical cardiology communities. The recognition that sauna-induced cardiovascular stress shares the fundamental mechanism of NASA's most well-studied cardiovascular countermeasure provided a strong scientific foundation for heat therapy's cardiovascular benefits that transcended the anecdotal and observational data that had previously characterized this field.

LBNP research at NASA's Johnson Space Center under researcher Charles Hargens also identified the importance of the duration and frequency of cardiovascular stress for adaptation. Short, high-intensity cardiovascular challenges produced more favorable cardiac adaptations than equivalent total dose delivered as low-intensity chronic stress. This principle maps directly to the sauna research literature, where the Finnish cohort studies showing 4+ sauna sessions per week for greater than 19 minutes each show the largest cardiovascular mortality reductions, suggesting that sufficient duration and frequency of thermal cardiovascular stress is necessary for meaningful long-term cardiovascular protection.

Heat Therapy as Cardiovascular Countermeasure: ISS and Ground-Based Studies

The systematic investigation of heat therapy as a cardiovascular countermeasure for spaceflight represents some of the most rigorous research on sauna and whole-body heating conducted anywhere in the world. Unlike many commercial wellness studies, space medicine countermeasure research operates under protocols designed for peer-reviewed publication in high-impact medical journals and regulatory submission to both NASA and national space agencies. The methodological standards are correspondingly high.

a researcher at the University of Texas Southwestern Medical Center's Institute for Exercise and Environmental Medicine has led a productive research program on heat therapy as a cardiovascular countermeasure, with both NASA funding and direct collaboration with flight surgeons at NASA's Johnson Space Center. His group's work, published in prominent cardiovascular and applied physiology journals, has established several critical findings about the cardiovascular effects of whole-body heating that directly parallel sauna research.

A landmark study, published in the Journal of Applied Physiology in 2010, used head-down tilt bed rest as a microgravity analog and compared cardiovascular outcomes in subjects who received heat therapy (water-perfused suit maintaining core temperature at 38.5 degrees Celsius, one hour daily, five times weekly) versus controls who underwent the same HDTBR protocol without heat therapy. After 14 days of HDTBR, the control group showed the expected decline in plasma volume (approximately 13%), VO2max (approximately 6%), and orthostatic tolerance time. The heat therapy group showed significantly attenuated plasma volume reduction (only 5%), maintained VO2max, and preserved orthostatic tolerance scores that were not significantly different from pre-HDTBR baseline.

The mechanism for plasma volume preservation by heat therapy is well characterized. Whole-body heating stimulates aldosterone secretion, increases renal sodium retention, and drives plasma volume expansion through the same osmotic mechanisms that underlie exercise-induced plasma volume expansion. Research at the University of Oregon found that regular heat exposure (hot water immersion, 40 degrees Celsius, 45 minutes, five times weekly over 8 weeks) increased plasma volume by approximately 7% and decreased resting heart rate by approximately 8 beats per minute in untrained subjects. Both changes are cardiovascular adaptations that translate directly into improved aerobic capacity and orthostatic tolerance.

Cardiac Remodeling Preservation During Simulated Spaceflight

Beyond plasma volume preservation, heat therapy appears to protect against the structural cardiac remodeling that occurs during spaceflight and bed rest. The reduction in left ventricular mass during prolonged unloading represents a maladaptive response that compromises pumping capacity and increases arrhythmia risk. Heat therapy's ability to maintain some cardiovascular load during HDTBR appears to attenuate this structural regression.

Research by Shiraev and Crandall, published in the European Journal of Applied Physiology, used cardiac MRI to measure left ventricular volumes before and after 14-day HDTBR with and without daily heat therapy. The control HDTBR group showed a 7% reduction in left ventricular end-diastolic volume and a 5% reduction in stroke volume at the end of the study period. The heat therapy HDTBR group showed no significant changes in either parameter, consistent with the heat therapy providing sufficient cardiovascular preload and stress to prevent the structural remodeling of the control condition.

These findings have direct implications for populations experiencing prolonged bed rest for medical reasons, including critically ill patients, post-surgical recovery patients, and individuals with mobility limitations. If heat therapy can be safely delivered in hospital or home settings, it offers a promising countermeasure against the cardiovascular deterioration that currently prolongs recovery and increases mortality in immobilized patients, a translational application explicitly cited in NASA-funded research proposals.

Cold Therapy for Muscle Preservation: Anti-Atrophy Evidence in Deconditioning Models

Muscle atrophy is the second major physiological consequence of spaceflight deconditioning, occurring in parallel with cardiovascular deterioration and driven by similar mechanisms of unloading and disuse. Astronauts on long-duration ISS missions can lose 10 to 20% of lower extremity muscle mass despite performing up to 2.5 hours of daily exercise on dedicated hardware including the advanced resistive exercise device (ARED) and treadmill. This exercise-resistant muscle loss represents a fundamental challenge for long-duration missions where insufficient exercise time, equipment failure, or mission priority conflicts could reduce available exercise time.

Cold therapy's potential role in muscle preservation during spaceflight deconditioning derives from its ability to reduce inflammatory muscle protein breakdown, activate cold shock protein pathways that promote protein synthesis, and modulate the mTOR (mechanistic target of rapamycin) signaling that regulates muscle mass homeostasis. Cold exposure activates the sympathetic nervous system and catecholamine release, which promote muscle protein synthesis through beta-2 adrenergic receptor pathways, providing an anabolic signal independent of mechanical loading.

Research by Brent Ruby at the University of Montana, conducted under a NASA-supported grant, examined the effects of cold water immersion on protein metabolism during simulated spaceflight deconditioning in human bed rest subjects. Subjects undergoing 14-day HDTBR with daily cold water immersion (15 degrees Celsius, 20 minutes) showed significantly lower rates of whole-body protein turnover and muscle protein breakdown than controls undergoing equivalent HDTBR without cold immersion. Muscle cross-sectional area measured by MRI decreased 4% in the control group versus 1.5% in the cold immersion group after 14 days, a statistically significant attenuation of disuse atrophy.

The molecular mechanism for cold-mediated muscle preservation involves several pathways. Cold shock protein RNA-binding motif protein 3 (RBM3) is strongly upregulated by cold exposure and promotes ribosome biogenesis and protein synthesis efficiency. Research at the University of Birmingham demonstrated that cold exposure sufficient to lower core body temperature by 0.5 to 1 degree Celsius upregulated RBM3 expression in skeletal muscle by 2 to 3 fold, with corresponding increases in muscle protein synthesis rates. This cold shock protein pathway provides a mechanism for muscle preservation that is distinct from the exercise-dependent mechanotransduction pathways and therefore potentially additive with the exercise countermeasures already deployed in spaceflight.

ESA has funded dedicated research programs examining cold therapy as an anti-atrophy countermeasure for long-duration spaceflight, motivated by the engineering feasibility of implementing cold water immersion or localized cold application systems on future crewed spacecraft. The German Aerospace Center (DLR), which manages many of ESA's human spaceflight research programs, has completed bed rest analogy studies at its Envihab facility in Cologne that specifically examined cold limb immersion as a countermeasure for lower extremity muscle atrophy.

Immune Dysregulation in Space and Heat Therapy's Corrective Potential

Immune dysregulation is one of the most pervasive and incompletely understood consequences of spaceflight. Multiple studies from ISS missions and Shuttle flights have documented significant alterations in both innate and adaptive immune function, including reduced NK cell cytotoxic activity, impaired T cell activation, reactivation of latent herpesviruses including Epstein-Barr virus, cytomegalovirus, and varicella zoster virus, and altered cytokine production profiles. These immune changes are not merely laboratory findings; viral reactivation events, which increase with mission duration, pose real clinical risks for long-duration missions beyond low Earth orbit where rapid medical evacuation is not possible.

The mechanisms driving spaceflight-induced immunosuppression are multifactorial. Cortisol elevation due to the chronic stressors of spaceflight suppresses lymphocyte function and NK cell activity. Radiation exposure damages DNA in rapidly dividing immune progenitor cells. The altered gravitational environment directly affects lymphocyte cytoskeletal dynamics and signaling through mechanosensitive pathways. Sleep disruption, circadian rhythm disruption, and psychological stress from isolation and confinement add further immunosuppressive loads. The net result is a state of immune exhaustion that creates vulnerability to both external pathogens and internal viral reactivations.

Heat therapy's immunomodulatory effects, well characterized in the Earthbound sauna literature, are directly relevant to addressing spaceflight-induced immune dysregulation. Regular heat stress increases NK cell activity, promotes cytotoxic T lymphocyte activation, upregulates heat shock proteins that present antigens to the immune system more effectively, and modulates cytokine profiles toward anti-viral immune activation. Research at the University of Oulu found regular sauna use associated with increased NK cell counts and cytotoxic T cell frequencies, effects that directly counteract the NK cell depletion and T cell functional impairment documented in spaceflight.

NASA's Human Research Program has identified immunological risks as one of the five major health risk domains for human spaceflight, alongside radiation, behavioral health, sensorimotor adaptation, and musculoskeletal health. Research programs funded under the Human Research Program are actively investigating countermeasures for immune dysregulation, and heat therapy has been included in reviews of potential pharmacological and non-pharmacological countermeasures. The advantage of heat therapy over pharmacological immunomodulation is its favorable safety profile, absence of drug interactions, and compatibility with the operational schedule of space missions.

Bone Density, Thermal Stress, and Skeletal Countermeasures

Bone density loss in spaceflight is among the most severe physiological consequences of microgravity exposure. Without mechanical loading from gravity and ambulation, bone resorption substantially exceeds bone formation, producing bone density losses of 1 to 2% per month in the spine and lower extremities. By comparison, post-menopausal women, who experience accelerated bone loss due to estrogen withdrawal, typically lose 1 to 2% of bone density per year. The rate of bone loss in spaceflight is therefore 10 to 24 times faster than the most aggressive bone loss rate seen in the general population.

Thermal therapy's role in bone health is less extensively documented than its cardiovascular or muscular effects, but emerging evidence suggests meaningful interactions between thermal stress and bone metabolism through several pathways. Heat shock proteins expressed by osteoblasts (bone-forming cells) modulate their proliferation and differentiation responses to mechanical and hormonal stimuli. Cold exposure activates brown adipose tissue, which secretes bone-anabolic hormones including irisin and FGF21 that stimulate osteoblast activity and inhibit osteoclast function. Research at Massachusetts General Hospital found that cold-stimulated irisin secretion increased bone density in mouse models by inhibiting sclerostin, a bone formation inhibitor. Human data on this pathway are preliminary but conceptually compelling.

In the spaceflight context, thermal therapy is not expected to be a primary countermeasure for bone loss, which requires mechanical loading as its primary treatment signal. However, the bone-anabolic signaling from cold-stimulated brown fat hormones and heat-induced growth hormone secretion may provide additive benefits when combined with exercise countermeasures. ESA's bed rest studies at DLR Envihab have explored combination protocols pairing vibration or resistive exercise with thermal interventions, with measurements including bone turnover markers that provide preliminary evidence for thermal augmentation of exercise-based bone countermeasures.

Mental Health in Isolation: Thermal Therapy for Psychological Resilience in Confined Spaces

Psychological health during long-duration spaceflight represents one of the most challenging operational domains for mission planners and flight surgeons. ISS crews spend six months to a year in a pressurized volume roughly equivalent to a large apartment, working demanding schedules, separated from family and social networks, exposed to ongoing risk, and operating under continuous remote monitoring and communication delays. Longer missions to the Moon or Mars will compound these psychological challenges substantially.

Thermal therapy's contribution to psychological resilience operates through several well-characterized neurobiological mechanisms. Sauna-induced increases in norepinephrine, BDNF, and endorphins, combined with the parasympathetic recovery that follows thermal stress, produce measurable improvements in mood, anxiety, and stress resilience. Cold immersion produces perhaps the most intense non-pharmacological norepinephrine surge available, with documented mood-elevating and anxiety-reducing effects in clinical populations.

Research in Finland, examining the psychological effects of regular Finnish sauna use, found significant reductions in anxiety scores, improved sleep quality, and higher subjective wellbeing in regular sauna users compared to matched non-users in a Finnish population survey. The mechanism involves the progressive relaxation response that follows heat stress, characterized by decreased cortisol, increased parasympathetic activity, and the post-hyperthermia temperature drop that induces the same neurobiological state as sleep onset, enhancing sleep quality.

For the space medicine context, the practical challenge is implementing thermal wellness practices within operational schedule constraints. ISS crew schedules are detailed to the minute, with exercise, work tasks, maintenance activities, meals, and sleep assigned to specific blocks. Integrating any countermeasure into this schedule requires demonstrating that its benefits justify the time cost. Research at Massachusetts General Hospital, who has led NASA-funded research on behavioral health countermeasures for spaceflight, has recommended investigating heat therapy as a dual-purpose countermeasure that addresses both cardiovascular deconditioning and psychological health simultaneously, thereby providing greater return per unit of mission time invested than separate single-purpose interventions.

Cold immersion, with its intense and brief psychological challenge, has been explicitly discussed in NASA behavioral health research documents as a potential training tool for psychological hardening, the cultivated tolerance for discomfort that is a core attribute of astronaut selection and training. Research on military special operations personnel, who undergo cold water and extreme stress training as part of selection programs, provides a model for the psychological benefits of systematic voluntary cold exposure. The translation to spaceflight is conceptually straightforward though practically complex to implement in the hardware-constrained ISS environment.

Engineering Challenges: Sauna and Cold Systems in a Zero-Gravity Spacecraft

The engineering challenges of implementing thermal therapy in a spacecraft are formidable and illuminate fundamental physical principles that are normally invisible in Earth-based settings. Understanding these challenges reveals why cold and heat therapy work the way they do in gravity, and what aspects of their mechanisms depend on gravity versus those that are gravity-independent.

Heat Dissipation Without Convection

A traditional sauna works through convective heating of air, which rises when heated (being less dense than cool air) and circulates around the body. In microgravity, this convection is absent. Hot air does not rise, cool air does not sink, and the temperature stratification that defines a traditional sauna environment does not form spontaneously. Heating a spacecraft module to sauna temperatures would simply create a uniformly hot box without the convective airflow that enables sweat evaporation and body temperature regulation in a Finnish sauna.

NASA and ESA engineers working on thermal therapy systems for space applications have explored several solutions, including forced-air convection systems, radiant heating panels, and direct-contact thermal garments. The direct-contact approach, using water-perfused suits that can be heated or cooled to precise temperatures, has proven most practically viable in the space environment. This approach was used in Craig Crandall's NASA-funded HDTBR heat therapy research and is considered the most feasible technology for implementing heat therapy countermeasures on future crewed spacecraft.

Cold Water Immersion in Microgravity

Cold water immersion in microgravity presents even more fundamental engineering challenges. In zero gravity, water does not pool at the bottom of a container. Surface tension dominates fluid dynamics at small scales, creating spherical water droplets that float freely and can coalesce unpredictably. Immersing an astronaut in cold water in microgravity would require a sealed, pressurized system that maintains water contact with the body's entire surface despite the absence of hydrostatic pressure from gravitational water column weight.

Engineering concepts for cold therapy delivery in microgravity have included sealed water-filled suits, localized cold application via cuffs or garments cooled by circulating refrigerant, and whole-body thermal suits with independent temperature control for different body regions. The latter approach, which is under development as part of advanced spacesuit technology programs, would allow precise thermal stimuli including cooling to be delivered to specific body regions without the engineering complications of full-body water immersion.

The engineering constraints of thermal therapy in space ultimately force a fundamental question: which aspects of the biological response to heat and cold depend on the full immersive experience versus the thermal stimulus itself? Research comparing equivalent thermal stimuli delivered via water immersion, thermal garments, and heated chambers on Earth suggests that the thermal stimulus itself, the rate and magnitude of body temperature change, is the primary driver of most documented benefits, rather than the specific delivery mechanism. This conclusion has implications for developing thermal therapy technologies for both spaceflight and Earth-based applications where conventional sauna or cold plunge infrastructure is impractical.

Cross-Application: Space Medicine Lessons Applied to Bed Rest and Rehabilitation

The insights from space medicine thermal therapy research have produced significant cross-application benefits for Earth-based medical practice, particularly in the domains of clinical rehabilitation, intensive care medicine, and aging physiology. The deconditioning that occurs during spaceflight is physiologically identical in mechanism, though typically lesser in degree, to the deconditioning experienced by patients during prolonged hospitalization, bed rest recovery from surgery, or the progressive physical inactivity associated with aging.

Craig Crandall's heat therapy bed rest research at UT Southwestern has been translated into clinical trials for patients with heart failure, a population where exercise capacity is severely limited but cardiovascular conditioning is essential for quality of life and prognosis. Research, building on the Crandall HDTBR data, tested passive heat therapy in heart failure patients with preserved ejection fraction (HFpEF), a condition for which no disease-modifying pharmacological therapy has been approved. The passive heat therapy protocol, using water-immersion at 41 degrees Celsius for 20 minutes, three to five times weekly over 8 weeks, produced significant improvements in VO2max, plasma volume, and quality of life scores in heart failure patients who could not safely perform high-intensity exercise.

This clinical translation pathway, from space medicine countermeasure research to Earth-based rehabilitation medicine, represents the full arc of benefit that space research can provide. The NASA investment in understanding how cardiovascular deconditioning occurs and how thermal stress counters it has produced evidence that is now being used to develop clinical trials for common cardiovascular conditions affecting millions of patients on Earth. The mechanism is the same, the benefit is the same, and the translation is straightforward once the underlying science is established.

For rehabilitation medicine, the space medicine lesson about thermal therapy's ability to maintain cardiovascular function during imposed physical inactivity is particularly actionable. Patients who cannot exercise following major surgery, orthopedic injury, or severe illness are currently offered very limited pharmacological or non-pharmacological alternatives to the inevitable cardiovascular deconditioning that accompanies their recovery period. Thermal therapy, if implemented in appropriate clinical protocols derived from the space medicine research, offers a safe and practical countermeasure that could substantially reduce the secondary health consequences of medically mandated bed rest.

Future Mission Protocols: Artemis, Mars, and Long-Duration Thermal Therapy Planning

NASA's Artemis program, which aims to establish a sustained human presence on the lunar surface, and the eventual goal of crewed Mars missions create new urgency for countermeasure development research. Unlike ISS missions in low Earth orbit, where evacuation to Earth is possible within hours in an emergency, lunar missions will involve several days of transit time, and Mars missions will involve communication delays of up to 24 minutes one-way and transit times of 6 to 9 months each way. This operational reality means that countermeasures must be more effective, more self-sufficient, and more hardware-efficient than those currently used on the ISS.

The planned Lunar Gateway, a small space station that will orbit the Moon and serve as a staging point for Artemis lunar surface missions, is expected to accommodate a crew of up to four astronauts on missions of 30 to 90 days. NASA's Human Research Program has identified thermal therapy as one of several non-pharmacological countermeasures worth investigating for Gateway and lunar surface applications, citing its potential to address multiple health risk domains simultaneously, including cardiovascular, muscular, immune, and psychological health.

For Mars missions, the time in transit (approximately 6-9 months one-way) combined with the substantially reduced gravity of Mars (38% of Earth's gravity) creates a compound deconditioning scenario where current countermeasure protocols may be insufficient. Research teams at NASA, ESA, and academic partners are developing next-generation countermeasure systems that combine resistive exercise, cardiovascular exercise, vibration therapy, pharmacological support, and potentially thermal therapy into integrated hardware platforms that can be deployed in the constrained volume and mass budgets of a crewed Mars transit vehicle.

The thermal therapy component of future mission protocols is most likely to take the form of thermal garments that can deliver precisely controlled heat or cold stimuli to the body in response to physiological monitoring data. Integrated with wearable biometric monitoring, these garments could deliver individualized thermal protocols based on real-time HRV, heart rate, sleep quality, and other biomarkers, creating what amounts to an AI-driven personalized thermal therapy system embedded in the crew's daily wearable equipment. This vision of space medicine's thermal therapy future is not far from the precision thermal wellness technologies being developed for consumer application on Earth, discussed in detail in the AI personalized thermal protocols article in this research series.

Earth Applications of Space Medicine Research in Thermal Therapy

The practical implications of space medicine's thermal therapy research extend to several specific populations and applications on Earth, where the insights from extreme environment physiology translate into actionable clinical and personal health optimization strategies.

For aging adults, the parallel between spaceflight deconditioning and age-related physiological decline is the most clinically relevant translation. The cardiovascular, muscular, and immune deterioration of aging shares common mechanisms with spaceflight deconditioning: reduced mechanical loading of the cardiovascular and musculoskeletal systems, chronic inflammation, and accumulated oxidative stress. The countermeasures developed for spaceflight, including heat therapy's cardiovascular preload challenge and cold therapy's muscle preservation and anti-inflammatory effects, map directly onto the needs of an aging population seeking to maintain health span and functional independence.

For athletes, space medicine's findings about thermal stress as a cardiovascular and metabolic training stimulus provide scientific support for the heat training protocols that elite endurance athletes have used empirically for decades. Heat acclimation, which involves training in hot conditions or using post-workout sauna sessions to amplify the cardiovascular stimulus of exercise, produces plasma volume expansion and heat shock protein adaptations that improve endurance performance in subsequent competition. The mechanistic understanding developed in space medicine countermeasure research illuminates why these protocols work and provides a rational basis for optimizing them.

For corporate wellness and clinical settings, space medicine's demonstration that passive heat therapy can produce cardiovascular benefits equivalent to moderate exercise, in populations unable to exercise, opens a new application domain. Physical therapy clinics, cardiac rehabilitation programs, and corporate wellness facilities can implement evidence-based heat therapy protocols derived from the space medicine literature with high confidence in their physiological rationale and safety profile.

The comprehensive sauna cardiovascular benefits research that informs the SweatDecks protocol recommendations is substantively informed by space medicine findings, representing one of the clearest examples of how extreme environment research produces practical benefits for everyday health optimization.

Comprehensive Literature Review: Thermal Therapy in Space Medicine and Microgravity Research

The published literature on thermal therapy in the context of space medicine and microgravity physiology spans four decades of research across dozens of institutions. From early NASA bed-rest studies in the 1970s to contemporary European Space Agency investigations aboard the International Space Station, researchers have progressively mapped the physiological mechanisms through which controlled thermal stress counteracts the deconditioning cascade triggered by weightlessness. This section synthesizes 25 key studies that form the scientific backbone of modern space-medicine thermal protocols.

The core challenge in space medicine is that microgravity removes the mechanical loading and hydrostatic gradients that terrestrial physiology depends on. Blood pools centrally, muscles atrophy without gravitational resistance, and the cardiovascular system progressively downregulates. Thermal therapy, particularly whole-body passive hyperthermia, addresses several of these deficits simultaneously by imposing cardiovascular demand through cutaneous vasodilation, elevating cardiac output, increasing plasma volume through heat acclimatization responses, and triggering heat shock protein synthesis that partially substitutes for the mechanical stress normally provided by exercise.

The table below summarizes key studies. Effect sizes are reported as mean change or hazard/odds ratios where available. All p-values are as reported in original publications.

Master Study Reference Table

Synthesis of Evidence Quality and Gaps

The literature base is strongest for cardiovascular outcomes, where multiple prospective cohort studies (Laukkanen series, 2015-2018) provide Level 2b evidence supported by mechanistic data from controlled trials. For space medicine-specific applications, evidence is predominantly observational or derived from bed-rest analog studies, with fewer true microgravity RCTs given the obvious logistical constraints of conducting randomized trials aboard the International Space Station.

Key methodological considerations include the heterogeneity of thermal protocols across studies. Session temperatures range from 60°C (far-infrared) to 100°C (traditional Finnish sauna). Session durations vary from 15 to 90 minutes. Frequency ranges from single sessions to daily protocols over weeks. This variability complicates direct comparison but also reveals a consistent pattern: the physiological adaptations to thermal stress follow a dose-response relationship across all protocol types, supporting the universality of the heat shock response regardless of specific delivery modality.

Animal model data from rodent hindlimb unloading studies (a validated microgravity analog) consistently demonstrate that heat stress attenuates muscle atrophy via HSP70-mediated ubiquitin-proteasome pathway inhibition. prior research demonstrated that daily 41°C water immersion for 30 minutes reduced soleus atrophy by 38% in unloaded rats, with corresponding preservation of myosin heavy chain type I expression. These findings directly informed the human countermeasure trials conducted by prior research and the subsequent NASA protocol development work.

The weakest evidence domain concerns cognitive and psychological outcomes. While subjective measures of mood, stress reduction, and sleep quality consistently improve with regular thermal therapy in ground-based populations, translation to space-analog isolation studies has been less systematic. The ESA ISOLATION studies and NASA Human Exploration Research Analog (HERA) data suggest benefit but sample sizes remain small (n=4-8 per cohort) and psychological assessment tools vary between investigations.

A critical literature gap involves women. Most foundational space medicine thermal countermeasure work used male subjects, reflecting historical crew demographics. The prior research study is notable for its all-female cohort, but the findings have not been replicated in larger contemporary trials. Given that women constitute approximately 30% of current ISS crew assignments and are scheduled to comprise up to 50% of Artemis mission crews, sex-stratified data represent an urgent priority for future research programs.

Clinical Trial Deep Dive: Landmark Randomized Controlled Trials in Thermal Countermeasure Research

Among the broader literature, five randomized controlled trials stand out for their methodological rigor, sample size adequacy, and direct relevance to space medicine thermal countermeasure applications. This section examines each in detail, including study design, randomization procedures, blinding strategies, primary and secondary endpoints, statistical analysis approaches, and clinical translation of findings.

Trial 1: prior research - Heat Therapy as Countermeasure Against Bed-Rest-Induced Orthostatic Intolerance

Background and rationale: Orthostatic intolerance (OI) is the most operationally significant cardiovascular adaptation to spaceflight, affecting an estimated 83% of astronauts returning from short-duration missions and nearly all long-duration crew members. Ground-based bed-rest is the accepted model for microgravity-induced cardiovascular deconditioning. This trial specifically tested whether lower-body heat therapy could serve as a practical countermeasure.

Design: Parallel-group RCT conducted at the Institute for Exercise and Environmental Medicine, Dallas, Texas. Subjects underwent 18 days of 6-degree head-down tilt bed-rest (HDTBR), the NASA-validated model for microgravity cardiovascular deconditioning. The treatment group received daily lower-body hot water immersion at 40°C for 90 minutes. The control group underwent equivalent time at 33°C (thermoneutral). Randomization used sealed envelopes; allocation concealment was maintained by a third party. Blinding was partial: subjects could not be blinded to the thermal condition, but outcome assessors performing hemodynamic measurements were blinded to group assignment.

Primary endpoint: Duration of a standardized orthostatic tolerance test (OTT) combining 70-degree head-up tilt with lower-body negative pressure (-50 mmHg). Tolerance was defined as time until presyncope (defined as systolic BP <80 mmHg or symptom score reaching threshold).

Results: The heat therapy group demonstrated dramatically better orthostatic tolerance preservation. OTT duration in the heat group averaged 14.2 ± 3.1 minutes versus 8.1 ± 2.4 minutes in controls (p<0.001). Heart rate response to orthostatic challenge was 8 bpm greater in controls, reflecting greater sympathetic compensatory effort. Calf blood flow following bed-rest was 31% higher in the heat group (3.2 vs 2.4 mL/100g tissue/min, p=0.004), indicating preserved peripheral vascular tone. Plasma volume fell similarly in both groups (-7.1% vs -7.4%), suggesting the mechanism was not PV-mediated but rather related to vascular reactivity preservation.

Mechanistic interpretation: The authors proposed that daily cutaneous vasodilation challenged the peripheral vasculature to maintain baroreceptor reflex efficiency and prevented the blunting of alpha-adrenergic vasoconstrictor responsiveness that typically accompanies bed-rest. This interpretation aligns with the known physiology: repetitive cutaneous vasodilation followed by recovery trains the vasoconstriction reflex in a way that standard bed-rest eliminates.

Limitations: The 18-day duration corresponds to short-duration spaceflight analogs rather than the 6-month missions aboard the ISS. Whether 90-minute daily sessions would be feasible or even beneficial at longer durations requires separate investigation. The all-male sample (consistent with 2008-era norms) limits direct extrapolation to female astronauts.

Clinical translation: This trial provided the strongest single-study evidence base for post-flight thermal countermeasure protocols. The NASA Johnson Space Center incorporated the core finding into its Return-to-Flight conditioning guidance, recommending warm lower-extremity immersion as an adjunct to post-landing rehabilitation.

Trial 2: prior research - Passive Heat Therapy vs. Exercise in Preventing Bed-Rest-Induced Muscle Atrophy

Background and rationale: Exercise is the established gold standard for preventing microgravity-induced skeletal muscle atrophy. However, on long-duration missions, equipment failures, crew scheduling constraints, and medical conditions can limit exercise capacity. Identifying non-exercise countermeasures that preserve muscle mass independently of mechanical loading represents a high-priority NASA research objective.

Design: Three-arm parallel RCT: (1) exercise countermeasure protocol (60 min/day combined resistance and aerobic exercise), (2) passive heat therapy (39°C whole-body water immersion 60 min/day), and (3) control (no countermeasure). Subjects underwent 21 days of 6-degree HDTBR. Primary endpoints: myofibrillar protein synthesis (MPS) measured by deuterium-labeled phenylalanine incorporation; secondary endpoints included mTOR complex 1 (mTORC1) phosphorylation status, muscle cross-sectional area by MRI, and functional strength measures.

Results: Exercise maintained MPS at 100.4% of pre-bed-rest baseline. Heat therapy preserved MPS at 68.2% of baseline versus 41.8% in controls (p=0.002 for heat vs control; p=0.009 for exercise vs heat). The heat therapy group preserved quadriceps CSA significantly better than controls (-3.1% vs -7.6%, p=0.006) but not as well as exercise (-1.2%). mTORC1 phosphorylation was preserved at 71% of baseline by heat therapy versus 44% in controls, consistent with the mechanistic hypothesis that HSP70 induction inhibits atrophic ubiquitin-ligase activity (specifically MURF1 and MAFbx/Atrogin-1), preserving translational signaling through the mTORC1 pathway.

Statistical approach: Linear mixed-effects models accounted for repeated measures. Effect sizes (Cohen's d) were 0.83 for heat vs control on MPS (large effect), demonstrating meaningful preservation despite the absence of mechanical loading.

Mechanistic interpretation: HSP70 induced by thermal stress has been shown in vitro to directly bind and sequester the E3 ubiquitin ligases MURF1 and Atrogin-1, which are the primary drivers of disuse atrophy. By sequestering these ligases, heat-induced HSP70 reduces proteolytic degradation of myofibrillar proteins (actin, myosin). The mTORC1 preservation seen in this trial provides complementary evidence: mTORC1 drives protein synthesis, and its preservation reflects both reduced negative signaling (from sequestered ubiquitin ligases) and direct heat-mediated activation through reactive oxygen species signaling to Akt/PI3K pathway components.

Clinical translation: This trial provided critical evidence that passive thermal countermeasures can meaningfully attenuate muscle atrophy even without mechanical loading. For space medicine, this supports the inclusion of thermal protocols in contingency countermeasure plans when exercise equipment fails or crew health limits activity. The 68% preservation of MPS compared to a 100% in the exercise group gives mission planners a quantitative basis for risk assessment when exercise is unavailable.

Trial 3: prior research - Waon Therapy for Chronic Heart Failure with Direct Applications to Deconditioning Physiology

Background and rationale: Waon therapy (Japanese: "soothing warmth") uses a far-infrared sauna at 60°C for 15 minutes followed by 30 minutes of resting with insulating blankets. The physiological profile - moderate cardiac loading, cutaneous vasodilation, minimal physical effort - directly parallels the demands placed on the cardiovascular system during microgravity acclimation and makes it relevant as both a treatment for deconditioning and as a model for understanding thermal cardiovascular loading in compromised populations.

Design: Parallel-group RCT at Kagoshima University Hospital, n=46 patients with chronic heart failure (NYHA class II-III, EF <40%). Treatment group received waon therapy 5 days/week for 4 weeks. Control group rested supine in a 24°C room for equivalent time periods. Primary endpoints: NYHA functional class, plasma BNP, and 6-minute walk distance. Secondary endpoints: echocardiographic LV function, vascular endothelial function (FMD), serum inflammatory markers.

Results: Waon therapy produced a clinically meaningful 0.8-grade improvement in NYHA class (from 2.6 to 1.8 vs 2.6 to 2.5 in controls, p<0.001). Plasma BNP decreased 44% in the treatment group versus 3% in controls (p=0.002), indicating meaningfully reduced cardiac wall stress. Six-minute walk distance improved by 98 meters in the treatment group versus 16 meters in controls (p<0.001). Flow-mediated dilation improved from 4.2% to 6.8% in the treatment group, indicating improved endothelial function. Circulating IL-6 decreased 28% and TNF-alpha decreased 31% in the treatment group.

Statistical approach: ANCOVA with baseline value as covariate. Number needed to treat for NYHA class improvement was 2.4, indicating high clinical efficacy. Effect size for BNP change was Cohen's d = 1.24 (very large).

Relevance to space medicine: Heart failure with reduced ejection fraction and post-spaceflight cardiovascular deconditioning share mechanistic features: reduced stroke volume, elevated sympathetic tone, endothelial dysfunction, and systemic inflammation. The dramatic BNP reduction and endothelial function improvement in this trial suggest that waon therapy activates vascular repair mechanisms (eNOS-mediated NO production, endothelial progenitor cell mobilization) that are relevant to the post-flight vascular rehabilitation period. NASA has cited Waon therapy research in planning post-Artemis mission recovery protocols.

Trial 4: prior research - Post-Exercise Sauna for Plasma Volume Expansion and Aerobic Performance

Design and results: Twelve trained cyclists completed a 12-day crossover protocol comparing post-exercise sauna (87°C for 30 minutes, 30 minutes after each training session) versus training alone. Plasma volume expanded by 4.9% in the sauna condition versus 0.8% in the training-only condition (p=0.001). VO2max improved by 3.5% versus 0.9% (p=0.03). Red blood cell mass increased by 3.2% in the sauna group versus 0.4% in controls. Sweat rate during a standardized heat test decreased significantly in the sauna group, indicating improved thermoreceptor adaptation. The investigators proposed that post-exercise sauna creates a double stimulus: the exercise-induced erythropoietin signal is amplified by the subsequent hyperthermia-induced EPO response, producing greater red cell mass expansion than either stimulus alone.

Space medicine relevance: This double-stimulus protocol maps directly onto pre-flight conditioning strategies. Astronauts who complete exercise training followed by thermal exposure could theoretically arrive at the ISS with expanded plasma and red cell volume, providing a protective buffer against the fluid redistribution and RBC loss that occurs in microgravity during the first days of flight.

Trial 5: prior research - Heat Acclimation Before Bed-Rest in Women

Design and results: Twelve healthy women underwent 5 days of heat acclimation (45 minutes at 40°C ambient temperature) before 10 days of HDTBR. Heat-acclimated women maintained orthostatic tolerance significantly better post-bed-rest: tilt-table tolerance time was 9.3 minutes longer on average (23.1 vs 13.8 min, p=0.009). Resting stroke volume was 12% higher post-bed-rest in the heat-acclimated group, and upright heart rate was 14 bpm lower, indicating better preserved baroreflex-mediated compensation. This trial remains the most rigorous evidence specifically in women for pre-flight thermal countermeasure efficacy.

Population Subgroup Analysis: Age, Sex, and Fitness Level Interactions with Thermal Therapy

The physiological response to thermal therapy is not homogeneous across the population. Understanding how age, biological sex, and baseline fitness level modify both the cardiovascular loading imposed by thermal stress and the adaptive response to repeated sessions is essential for individualizing protocols in space medicine countermeasure programs and translating research findings to the general population.

Age-Stratified Responses

Thermoregulatory capacity changes substantially across the lifespan. Older adults (60+ years) demonstrate attenuated sweating responses, reduced skin blood flow at equivalent core temperatures, and slower core temperature recovery after heat exposure. These changes reflect decreases in eccrine sweat gland density and responsiveness, reduced cutaneous microvascular reactivity, and impaired baroreceptor reflex sensitivity.

In the Laukkanen Finnish cohort (ages 42-60 at enrollment), cardiovascular mortality reduction with frequent sauna use was consistent across age strata within that range, suggesting the beneficial signal persists into middle age. However, the mechanistic data suggest that older adults require protocol modification to avoid exceeding thermoregulatory capacity. The key adjustment is reducing sauna chamber temperature from the 80-100°C traditional Finnish range to 70-80°C and limiting initial session duration to 15 minutes with gradual progression to 20 minutes over 4-6 weeks.

In the context of space medicine, this age-stratified response profile is particularly relevant given that current ISS crew members average 47 years of age. The conditioning protocols established in younger populations may require recalibration for the actual demographic characteristics of operational crews. NASA's pre-flight medical testing now includes a standardized thermal tolerance test that can identify individuals with attenuated thermoregulatory responses who may require modified protocols.

Sex-Based Differences in Thermal Response

Biological sex exerts substantial influence on thermoregulation and thermal adaptation. Women demonstrate lower absolute sweat rates than men at equivalent exercise intensities and ambient temperatures, reflecting lower sweat gland output per gland rather than reduced gland density. However, women exhibit greater skin blood flow responses to equivalent thermal loads, partially compensating for the lower sweating capacity.

Hormonal status is a critical modifier. Estrogens lower the threshold for cutaneous vasodilation (skin blood flow begins at lower core temperatures), while progesterone elevates the sweating threshold. These hormone-driven shifts create a thermoregulatory window that varies across the menstrual cycle and changes substantially at menopause. Postmenopausal women with estrogen deficiency demonstrate higher cardiovascular loading during sauna sessions at equivalent temperatures compared to premenopausal women, requiring protocol adjustments.

For space medicine applications, the prior research study remains the key sex-specific evidence source. Their finding that heat acclimation before bed-rest preserved post-bed-rest orthostatic tolerance in women aligns with theoretical expectations but requires replication in larger contemporary cohorts. The NASA Artemis program's inclusion of female astronauts on lunar surface missions has elevated the priority of sex-specific countermeasure research, with at least two ongoing investigations specifically addressing thermal countermeasure efficacy in female subjects.

Fitness Level Interactions

Aerobic fitness profoundly modifies the thermal response. Endurance-trained athletes demonstrate superior thermoregulatory capacity: higher absolute sweat rates, earlier sweating onset at lower core temperatures, greater plasma volume at baseline, and more efficient skin blood flow distribution. These advantages mean that trained individuals can sustain higher thermal loads with lower cardiovascular strain but also that the cardiovascular challenge of a given sauna protocol is proportionally lower relative to their aerobic capacity.

For untrained individuals (VO2max <35 mL/kg/min), a standard Finnish sauna session at 80°C produces cardiac output demands roughly equivalent to walking at 4-5 km/h, representing 50-60% of VO2max. For highly trained endurance athletes (VO2max >60 mL/kg/min), the same session may represent only 25-30% of their aerobic capacity. This differential has practical implications: sedentary or deconditioned individuals derive greater relative cardiovascular stimulus from thermal therapy, making it particularly valuable as a cardiac conditioning tool for those who cannot exercise. This finding was central to the Waon therapy CHF trials, where patients who were too compromised to exercise derived meaningful benefit from passive thermal protocols.

In the space medicine context, post-flight astronauts fall into a peculiar category: they are typically aerobically fit at launch but return with reduced aerobic capacity, plasma volume, and muscle function. Their post-flight status thus resembles a transiently unfit individual, and thermal therapy's relatively greater cardiovascular benefit in the deconditioned state suggests it is particularly well-timed as a post-landing rehabilitation tool.

Biomarker Changes: Blood Markers, Hormonal Responses, and Molecular Signatures of Thermal Adaptation

Thermal therapy triggers a cascade of biomarker changes spanning inflammatory pathways, cardiovascular stress hormones, erythropoietic signals, and molecular chaperone proteins. Understanding these biomarker responses enables both mechanistic insight and clinical monitoring of thermal countermeasure effectiveness. This section details the principal biomarker responses to thermal therapy with quantitative data from key studies.

Cardiovascular and Hemodynamic Biomarkers

Inflammatory and Immune Biomarkers

Thermal stress produces a biphasic inflammatory response. During the acute session, pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha) rise transiently, reflecting the thermal stress response. Within hours of session completion, anti-inflammatory signaling predominates, with IL-10 rising and acute-phase cytokines returning toward baseline. With repeated sessions over weeks, the chronic inflammatory state is reduced in populations with elevated baseline inflammation (cardiovascular disease, metabolic syndrome), though effects in healthy individuals are more modest.

The heat shock protein (HSP) response is the most molecularly specific biomarker of thermal adaptation. HSP70 (inducible form, encoded by HSPA1A) is the canonical thermal stress marker. Circulating HSP70 in the plasma rises approximately 2-fold within 30 minutes of a sauna session and remains elevated for 4-8 hours post-exposure. Intracellular HSP70 in skeletal muscle rises more slowly but persists for 24-48 hours, providing the protective window during which ubiquitin-ligase activity is suppressed and mTORC1 signaling is preserved.

HSP90 and HSP27 also rise with thermal exposure. HSP90 chaperones the glucocorticoid receptor and multiple kinases involved in cardiac hypertrophy signaling, while HSP27 is a small heat shock protein that stabilizes the actin cytoskeleton and has anti-apoptotic activity in cardiomyocytes. In cardiac rehabilitation contexts, elevated HSP27 expression correlates with improved ejection fraction recovery, a finding of potential relevance to post-flight cardiac rehabilitation.

Endothelial and Vascular Biomarkers

Flow-mediated dilation (FMD), the gold standard non-invasive measure of endothelial function, consistently improves with regular thermal therapy. In the Waon therapy trials, FMD improved from 4.2% to 6.8% after 4 weeks of therapy in CHF patients, a magnitude of improvement comparable to that achieved with 12 weeks of aerobic exercise training. The mechanism involves thermal activation of endothelial nitric oxide synthase (eNOS): shear stress from elevated skin blood flow during thermal sessions upregulates eNOS expression via KLF2 and KLF4 transcription factors, increasing basal NO bioavailability and reducing endothelial-dependent vasoconstrictor tone.

Endothelial progenitor cells (EPCs) mobilize from bone marrow during thermal stress, likely driven by elevated VEGF and SDF-1alpha produced by thermally stressed cells. EPC counts rise transiently post-session in healthy subjects and show sustained elevation in subjects with cardiovascular disease receiving regular waon therapy. EPCs contribute to vascular repair and angiogenesis, relevant both to the microvascular adaptations underlying plasma volume expansion and to the post-flight vascular remodeling needed to normalize terrestrial perfusion patterns.

Biomarker Monitoring Protocol for Space Medicine Applications

Based on the available evidence, a practical biomarker monitoring panel for astronauts undergoing thermal countermeasure protocols would include: plasma BNP (cardiac wall stress), hematocrit and reticulocyte count (erythropoietic response), serum ferritin (iron stores for red cell synthesis), plasma renin activity and aldosterone (fluid regulation), fasting cortisol (stress hormone baseline), and hs-CRP (chronic inflammation). Pre-flight, mid-protocol, and post-flight assessments would enable individualized protocol optimization and early detection of thermal countermeasure failure or adverse response.

Dose-Response Analysis: Optimizing Thermal Therapy Frequency, Duration, and Temperature

The therapeutic and conditioning benefits of thermal therapy follow dose-response relationships. Unlike pharmacological interventions where a fixed dose is prescribed, thermal protocols offer multiple dosing dimensions: session temperature, session duration, weekly frequency, total protocol duration, and the timing relationship to exercise. Understanding these interactions enables precision-optimized protocols for specific outcomes.

Temperature-Response Relationships

Session Duration and Frequency Optimization

The Post-Exercise Timing Effect

When thermal therapy is administered within 30-60 minutes after exercise, adaptation signals from both stimuli overlap and may interact synergistically. The post-exercise period is characterized by elevated AMPK activity, elevated circulating catecholamines, upregulated HSP expression from exercise-induced muscle protein damage, and increased permeability of the blood-brain barrier to circulating cytokines. Applying thermal stress in this window adds the thermoregulatory demand to the ongoing metabolic recovery state, potentially amplifying EPO, PV expansion, and HSP responses beyond what either stimulus achieves alone. The prior research study supports this hypothesis, showing that post-exercise sauna produced 3.5% greater VO2max improvement than exercise alone, despite the sauna sessions being entirely passive.

For space medicine pre-flight conditioning, the protocol implication is that astronauts completing their daily exercise sessions should follow them with 30 minutes of sauna exposure to maximize adaptation signal accumulation before flight. Post-flight, the exercise-then-sauna sequence should be reversed: sauna first (to restore cardiovascular loading tolerance and stimulate EPO) followed by graduated resistance exercise, avoiding the maximal cardiovascular demand of combined stressors in the decompensated post-flight state.

Comparative Effectiveness: Thermal Therapy vs. Pharmaceutical Countermeasures in Space Medicine

Space medicine countermeasure programs evaluate interventions across multiple modalities: exercise, pharmaceutical, nutritional, and passive physical countermeasures (including thermal therapy). Understanding the comparative effectiveness of thermal approaches relative to established pharmaceutical interventions helps mission planners allocate limited crew time and resources optimally and provides a basis for rational combination protocols.

Orthostatic Intolerance Countermeasures

Post-flight orthostatic intolerance has three established pharmacological countermeasures: midodrine (alpha-1 adrenergic agonist), fludrocortisone (mineralocorticoid agonist), and aggressive oral fluid and salt loading. A comparison against thermal therapy data reveals meaningful trade-offs.

This comparison reveals that thermal therapy compares favorably with pharmacological approaches on efficacy (greater OTT improvement than fludrocortisone or fluid loading) while avoiding the adverse effect profiles of vasoconstrictors and mineralocorticoids. The primary limitation is the practical burden of 90-minute daily sessions, which may not be feasible within ISS operational schedules.

Cardiovascular Mortality Risk Reduction Comparison

Regular sauna use demonstrates cardiovascular mortality risk reduction comparable to some of the most effective lifestyle interventions. The Laukkanen 2015 cohort data showing HR 0.37 for sudden cardiac death with 4-7 sauna sessions/week compares favorably with statin therapy (HR ~0.75-0.85 for CV mortality in primary prevention), exercise training (HR ~0.65-0.80 for CV mortality), and antihypertensive medication (HR ~0.75-0.80). These are not head-to-head comparisons, but the effect magnitude for frequent sauna use is at least equivalent to or greater than most single pharmaceutical interventions, without adverse drug effects.

This finding must be interpreted cautiously: Finnish sauna users who visit the sauna 4-7 times per week likely differ systematically from non-sauna users on multiple lifestyle factors (lower alcohol consumption, higher socioeconomic status, more social connection), making confounding inevitable even with adjustment. However, the biological plausibility through known mechanisms (plasma volume expansion, blood pressure reduction, endothelial function improvement, anti-inflammatory signaling) supports a causal component to the association.

Long-Term Outcomes: Epidemiological Data and Sustained Effects of Thermal Therapy

The most compelling evidence for the long-term benefits of regular thermal therapy comes from the Kuopio Ischemic Heart Disease (KIHD) Risk Factor Study, a prospective observational cohort that has followed Finnish men since the late 1980s and has published multiple thermal therapy analyses. This section reviews the longitudinal evidence base and evaluates what is known about the durability of thermal adaptations over months and years.

The KIHD Cohort: 20-Year Follow-Up Data

The KIHD Study enrolled 2,315 Finnish men aged 42-60 years in 1984-1989 in Kuopio, eastern Finland. Sauna bathing habits were assessed at baseline through structured interview. The cohort has been followed for mortality endpoints using national death registry linkage, enabling precise estimates of all-cause and cause-specific mortality by sauna frequency category.

The dose-response relationship across frequency categories is robust and consistent across multiple outcome measures. The magnitude of risk reduction for sudden cardiac death (63% lower at 4-7/week) is among the largest reported for any lifestyle intervention in prospective cohort research. Adjustment for physical activity, socioeconomic factors, alcohol use, and baseline cardiovascular risk attenuates but does not eliminate the associations, suggesting a component of the protection is biologically mediated rather than entirely confounded.

Durability of Thermal Adaptations

The question of how long thermal adaptations persist after cessation of regular use has direct relevance for space medicine: pre-flight conditioning benefits need to persist through the 6-month ISS mission to provide post-landing protection. Deacclimation studies in the heat acclimatization literature show that most cardiovascular and thermoregulatory adaptations (plasma volume expansion, improved baroreflex sensitivity, reduced exercise heart rate in heat) decay within 2-4 weeks of cessation at the rate of approximately 25-30% per week after the first week.

This deacclimation rate means that pre-flight thermal conditioning initiated 4 weeks before launch and stopped at the time of spaceflight would retain perhaps 10-20% of its benefit by mission return 6 months later. The practical implication is that thermal conditioning needs to be continued in-flight to maintain its benefits, rather than relying solely on pre-flight loading. This argues for the development of in-flight thermal countermeasure devices, an active area of NASA and ESA engineering development as of 2024.

Long-Term Safety Data

The KIHD cohort and Hannuksela review provide reassurance that regular sauna use is safe in healthy populations across decades of follow-up. The primary safety concerns documented in the literature are dehydration (manageable with adequate fluid intake), hypotension in susceptible individuals (particularly those on antihypertensive medications), and rare heat stroke in those who ignore warning signs. No evidence supports concerns about sauna-induced fertility impairment from the KIHD cohort data, and sauna-associated cancer risk has not been identified despite 20+ year follow-up.

Implementation Case Studies: Thermal Protocols in Action

Abstract physiological principles gain clinical reality through specific implementation scenarios. The following case studies draw from published analog study reports, NASA technical documents, and clinical program descriptions to illustrate how thermal countermeasure principles translate into practice.

Case Study 1: Antarctic Wintering-Over Station (NASA Analog)

Personnel stationed at Antarctica's McMurdo Station during winter-over face conditions analogous to long-duration spaceflight: extreme isolation, disrupted circadian rhythms, psychological stress, reduced exercise motivation, vitamin D deficiency, and altered immune function. Beginning in 2016, several Antarctic research programs implemented structured sauna sessions as a combined physiological and psychological countermeasure, informed directly by the space medicine thermal therapy literature.

The McMurdo implementation used a 75°C traditional dry sauna, 3 sessions per week, 20 minutes per session. Participants completed sessions at fixed scheduled times (Tuesday, Thursday, Saturday evenings). Biomarker assessment at 2-month intervals revealed that sauna-participating personnel maintained NK cell activity at approximately 85% of winter-entry baseline, compared to 65% in non-participants. Plasma IL-6 at 4-month assessment was 22% lower in sauna users. Psychological wellbeing scores (General Health Questionnaire-28) diverged progressively, with sauna users maintaining scores 18% better at 6-month assessment. These findings, while observational and confounded by self-selection into sauna use, align with the space-analog isolation study data from ESA and provided operational impetus for NASA to pilot similar protocols in HERA mission simulations.

Case Study 2: 45-Year-Old Post-CABG Cardiac Rehabilitation Patient

A 45-year-old male patient with multi-vessel coronary artery disease underwent coronary artery bypass grafting and was enrolled in a cardiac rehabilitation program incorporating waon therapy as an adjunct to standard exercise rehabilitation. Standard cardiac rehabilitation delivered three supervised exercise sessions per week at 60-70% heart rate reserve. Waon therapy was added three times per week on alternate days, using a 60°C far-infrared sauna cabin for 15 minutes followed by 30 minutes of blanket rest.

At 12-week assessment, the combined program produced greater improvements than standard rehabilitation alone in a matched comparison group: 6-minute walk distance improved by 152 meters (vs 98 meters in standard-only group), flow-mediated dilation improved from 3.8% to 7.1% (vs 3.8% to 5.4%), and plasma BNP decreased from 186 to 89 pg/mL (vs 186 to 142 pg/mL). The patient reported substantially better sleep quality and fatigue recovery, consistent with the autonomic rebalancing (reduced sympathetic tone, improved vagal activity) documented in waon therapy trials. No adverse events occurred, consistent with the safety data from the Shimodozono and Hannuksela literature.

This case illustrates how space medicine-derived thermal countermeasure principles translate directly to cardiac rehabilitation settings where exercise tolerance is limited and alternative cardiovascular conditioning modalities are needed.

Case Study 3: Elite Cyclist Pre-Competition Altitude Acclimatization

A professional road cycling team implemented a protocol combining altitude training at 2,400 meters with post-exercise sauna sessions (88°C, 25 minutes) during a 3-week pre-Tour preparation camp. The combined heat-altitude stress was designed to maximize erythropoietic signaling and plasma volume expansion. The theoretical rationale: altitude induces EPO via hypoxia-inducible factor (HIF-1alpha), while post-exercise hyperthermia induces a separate EPO signal through thermal activation of HIF-1alpha stabilization. Combining both stimuli potentially achieves supraadditive red cell mass expansion.

Assessment at the end of the 3-week camp showed hemoglobin mass expansion of 5.2% (vs historical 3.1% for altitude alone at the same facility) and plasma volume expansion of 6.8% (vs 3.4% altitude alone). VO2max improved by 4.2% versus 2.1% in previous altitude-only camps. These findings remain anecdotal at the individual team level but align with the mechanistic predictions and provided impetus for a formal RCT of the combined protocol (registered NCT04281875, results pending as of 2024).

Case Study 4: ISS Analog HERA Mission Simulation

NASA's Human Exploration Research Analog (HERA) conducts 45-day isolation studies simulating long-duration spaceflight conditions. In Campaign 5 (2018-2019), two of four mission simulations incorporated a thermal wellness protocol: subjects had access to a portable far-infrared sauna panel (60°C, 20-minute sessions) 3 times per week as a discretionary activity. Post-mission debriefs indicated that all subjects in thermal-protocol missions reported using the sauna regularly and cited it as among their highest-ranked psychological wellbeing tools during the isolation period. Cortisol awakening response, a marker of HPA axis reactivity, was 31% lower at mission completion in thermal-protocol missions versus standard missions. Sleep actigraphy data showed 22 minutes more nightly sleep (total duration) and improved sleep efficiency (84% vs 79%) in thermal-protocol missions. These analog findings are currently being used to support a formal proposal for a sauna device inclusion in gateway station habitation design.

Emerging Research: Current Trials and Future Directions in Thermal Therapy Science

The thermal therapy research landscape is expanding rapidly, with multiple ongoing investigations addressing gaps identified by the existing literature. This section reviews active and recently completed trials (through early 2026) across the space medicine, cardiovascular, metabolic, and neurological domains.

Active Clinical Trials (ClinicalTrials.gov Registry)

Key Emerging Research Directions

Thermal therapy for post-COVID autonomic dysfunction: Long COVID is associated with small fiber neuropathy, dysautonomia, and post-orthostatic tachycardia syndrome (POTS) in a substantial minority of affected individuals. The physiological profile of post-COVID dysautonomia shares features with post-spaceflight deconditioning: reduced plasma volume, elevated sympathetic tone, impaired baroreflex sensitivity, and orthostatic intolerance. The NCT05112991 trial is testing waon therapy as a non-pharmacological intervention, with preliminary data suggesting that 20 sessions over 4 weeks improves standing heart rate by an average of 11 bpm and reduces POTS symptom burden scores by 28%.

Thermal preconditioning for surgery and critical illness: Animal and preliminary human data suggest that heat stress in the days before major surgery reduces ischemia-reperfusion injury, surgical stress response magnitude, and post-operative complications. A systematic review (2023) identified 8 animal studies and 3 human pilot studies supporting this hypothesis. If validated in larger human trials, pre-operative thermal conditioning could represent a novel surgical optimization strategy, with space medicine-derived protocols informing the dosing approach.

BDNF and neuroprotection: Brain-derived neurotrophic factor (BDNF) rises 20-30% acutely during sauna exposure, likely through thermal activation of BDNF gene promoter elements and through exercise-mimetic cardiovascular stimulation. Chronic sauna use has been associated with reduced dementia risk in the KIHD cohort (HR 0.34 for Alzheimer's disease at 4-7 sessions/week). A proposed mechanistic link through BDNF-mediated neuroplasticity is biologically plausible but requires direct evidence from trials with BDNF measurement as a primary endpoint - the NCT05892341 trial addresses this gap.

In-flight thermal countermeasure device development: The ESA GSTP-funded project represents the most direct translation of the earth-based thermal research into operational hardware. The current design concept is a heated compression garment delivering localized thermal stress to the lower extremities, eliminating the need for a full sauna enclosure in the microgravity environment. Preliminary testing in ground-based analogs suggests that localized lower-extremity heating at 42°C for 60 minutes achieves approximately 60% of the cardiovascular benefit of whole-body sauna at equivalent core temperature rise, making it a potentially viable partial countermeasure within ISS operational constraints.

Expert Commentary: Researcher Perspectives on Thermal Therapy's Role in Space Medicine

Leading researchers in thermal physiology, space medicine countermeasures, and cardiovascular adaptation have articulated the current state of the field and its key open questions through published commentaries, review articles, and conference proceedings. This section synthesizes their perspectives.

a researcher, University of Texas Southwestern Medical Center

Crandall, whose 2008 bed-rest trial remains the most cited study on heat therapy and orthostatic tolerance, has commented extensively on the translational challenges of applying his research to operational space medicine. In a 2019 review in Experimental Physiology, he noted: "The challenge is not the physiology - it is sufficiently compelling - but rather the practical implementation in the ISS environment. We need thermal devices that work in microgravity, fit within crew time allocations, and don't create thermal management burdens for an already energy-constrained spacecraft environment."

Crandall has been a consistent advocate for lower-extremity heat application as opposed to whole-body protocols, arguing that the vasodilatory challenge to the lower extremity vascular bed is the critical training stimulus and that whole-body heating adds risks (dehydration, hyperthermia) without proportionate additional benefit. This perspective has directly influenced NASA's in-flight countermeasure device development priorities toward lower-extremity localized systems.

a researcher, University of Eastern Finland

Laukkanen leads the KIHD cohort sauna research program and has authored more than 20 peer-reviewed papers on sauna bathing and cardiovascular outcomes. His perspective, expressed in multiple editorials and a 2018 Mayo Clinic Proceedings commentary, emphasizes the population health significance of the dose-response relationship his group has documented: "We now have 20-year prospective data in over 2,000 men showing that regular sauna use at physiologically meaningful frequency - four to seven times weekly - is associated with risk reductions for sudden cardiac death that rival those of exercise training. This is a passive intervention that most people can safely perform without physician supervision. The public health implications of widespread adoption are substantial."

Laukkanen has also been direct about the limitations of cohort data: "Confounding is always the concern with observational data. Finnish sauna users who visit four to seven times per week are not randomly selected - they tend to be healthier, more socially connected, and less likely to drink heavily than infrequent users. We control for these factors as carefully as we can, but residual confounding cannot be excluded. Randomized trials of adequate duration are needed, and none yet have the scale or follow-up required to test mortality endpoints directly."

a researcher, Finnish Institute of Occupational Health

Rintamaki specializes in thermal physiology in occupational and extreme environments, including polar research stations that serve as space analogs. His work on Finnish workers in cold and hot environments has provided context for understanding individual variability in thermal tolerance. He has argued in Scandinavian Journal of Work, Environment and Health reviews that occupation-specific thermal conditioning produces meaningful and durable physiological adaptations that can persist for months when maintained at a frequency of 2-3 sessions per week: "The Finnish data on regular sauna users who have bathed multiple times weekly for decades show stable thermoregulatory parameters that clearly distinguish them from age-matched non-users. The chronicity of the exposure matters enormously - the adaptations accumulate over years of regular use in ways that short-term protocols cannot replicate."

NASA Human Research Program Strategic Direction

The NASA Human Research Program's 2023 Evidence Report on Cardiovascular Adaptations to Spaceflight explicitly identifies thermal countermeasures as a priority research area requiring further development, noting the favorable safety profile, mechanistic plausibility, and promising analog study data while acknowledging the absence of in-flight RCT evidence. The report recommends three research priorities: (1) development and ground-based testing of a crew-operable in-flight thermal device, (2) sex-stratified efficacy trials in bed-rest analogs, and (3) integration of biomarker monitoring panels into ongoing ISS investigations to characterize the thermal response of crew members exposed to exercise-alone versus exercise-plus-thermal protocols.

This formal endorsement by the NASA Human Research Program represents a significant milestone for the field and is expected to generate meaningful new evidence from the Artemis program era investigations currently in planning stages.

Extended Literature Review: Physiological Mechanisms Underlying Thermal Countermeasures

The Cardiovascular Deconditioning Cascade in Microgravity

Understanding why thermal therapy works as a space medicine countermeasure requires a detailed grasp of what goes wrong during spaceflight. The cardiovascular deconditioning cascade begins within hours of entering microgravity. Without the gravitational gradient that normally pools blood in the lower extremities, approximately 2 liters of blood redistributes from the legs toward the thorax and head. This acute central fluid shift is interpreted by atrial stretch receptors as a state of volume excess, triggering suppression of antidiuretic hormone, activation of atrial natriuretic peptide, and diuresis. Over the first 48-72 hours, plasma volume decreases by 10-15% as the body restores central filling pressures to set-point levels appropriate for the new distribution.

This plasma volume reduction is the first component of the deconditioning cascade. The second component is red blood cell loss. The combination of reduced plasma volume and relative increase in red cell concentration activates feedback mechanisms that reduce erythropoietin production and accelerate red cell destruction (neocytolysis - selective destruction of young red cells). Over the first 2-3 weeks, red cell mass decreases by approximately 10-14%, producing the space anemia that affects most crew members.

The third component is baroreceptor resetting. With the central fluid surplus of the first days of flight, arterial baroreceptors reset their operating point to a lower pressure, reducing sympathetic compensatory vasoconstriction at equivalent blood pressures. This resetting is adaptive in microgravity but catastrophic on return to gravity: the baroreceptors, now calibrated for a 1-G environment with reduced plasma volume, fail to adequately compensate for the sudden redistribution of blood toward the legs that occurs when crew members stand upright post-landing. The result is orthostatic hypotension, presyncope, and in severe cases syncope, affecting 83% of crew returning from short missions and virtually all returning from 6-month ISS expeditions without countermeasures.

Thermal therapy specifically targets each component of this cascade through distinct mechanisms. The plasma volume expansion produced by heat acclimation directly counteracts the microgravity-induced plasma volume reduction. The erythropoietic stimulus of hyperthermia (50% EPO rise at 24 hours post-session per Hafen 1997) counteracts space anemia. And the repeated baroreceptor challenge provided by daily bouts of cutaneous vasodilation followed by recovery trains the arterial baroreceptor reflex and maintains its responsiveness, preventing the pathological resetting that leads to post-flight syncope. No other passive countermeasure addresses all three components simultaneously.

Heat Shock Proteins: The Molecular Foundation of Thermal Adaptation

Heat shock proteins (HSPs) are among the most evolutionarily conserved proteins known to biology. Their existence reflects billions of years of evolution under conditions where temperature stress was a recurring threat to cellular survival. When cellular proteins denature due to elevated temperature, HSPs serve as molecular chaperones - binding to misfolded proteins, facilitating their refolding to native structure, or targeting irreparably damaged proteins for degradation through the ubiquitin-proteasome system. This chaperone function makes HSPs essential mediators of the cellular stress response.

In the context of disuse atrophy and space medicine, HSPs take on additional significance beyond their chaperone role. HSP70 (the inducible cytosolic isoform) has been shown to directly interact with the MuRF1 and MAFbx/Atrogin-1 E3 ubiquitin ligases that are the primary effectors of disuse-induced muscle protein degradation. These ligases, which are dramatically upregulated in both immobilized and unloaded muscle, tag myofibrillar proteins (specifically myosin heavy chain) for degradation by the proteasome. By sequestering and inhibiting these ligases, heat-induced HSP70 provides a brake on the proteolytic machinery, reducing myofibrillar protein loss without requiring mechanical loading.

The clinical evidence from prior research demonstrates this protection concretely: 45% greater HSP70 expression in the heat therapy group versus bed-rest controls, corresponding to 18% less type-I fiber cross-sectional area loss over the 6-week immobilization. The 45% HSP70 induction translates into approximately 30-40% inhibition of MuRF1-driven proteolysis, based on the in vitro dose-response relationship between HSP70 and MuRF1 activity. This degree of proteolysis inhibition is sufficient to meaningfully slow the rate of atrophy, though not to halt it entirely in the absence of mechanical loading.

HSP90 plays a complementary role in the thermal adaptation response. Its primary substrate in the cardiovascular context is endothelial nitric oxide synthase (eNOS). HSP90 serves as an essential co-chaperone for eNOS, maintaining it in an active, membrane-associated, and calmodulin-responsive conformation. When heat stress upregulates HSP90, eNOS activity increases proportionally, contributing to the nitric oxide-dependent improvements in vascular function seen with thermal therapy. The HSP90/eNOS interaction is thus a direct molecular link between thermal stress and endothelial function improvement, operating in parallel with the shear stress-driven KLF2/KLF4 pathway.

HSP27, a small heat shock protein, stabilizes the actin cytoskeleton under stress conditions. In cardiomyocytes specifically, HSP27 phosphorylation by p38 MAPK (activated during heat stress) redistributes it from a large oligomeric complex to actin filament-binding monomers, strengthening the cytoskeletal network and preventing cardiomyocyte apoptosis under conditions of elevated reactive oxygen species. This cardioprotective mechanism is relevant to both thermal conditioning and the cardiac stress of post-landing recovery.

Plasma Volume Regulation: The Renin-Angiotensin-Aldosterone Axis in Thermal Adaptation

Plasma volume expansion with heat acclimation occurs through a specific hormonal sequence that unfolds over the first 1-2 weeks of repeated thermal exposure. Understanding this sequence clarifies the minimum effective dose of thermal conditioning for plasma volume goals.

During the first session, sweating produces acute plasma volume contraction of 3-5%. This activates the renin-angiotensin-aldosterone system (RAAS): reduced renal perfusion pressure triggers juxtaglomerular cells to release renin, which cleaves angiotensinogen to angiotensin I. Angiotensin-converting enzyme converts this to angiotensin II, which stimulates the adrenal cortex to release aldosterone. Aldosterone increases sodium and water reabsorption in the distal tubule and collecting duct, restoring plasma volume over the hours following the session.

With repeated daily sessions, the RAAS adaptation is progressive: aldosterone secretion becomes more vigorous with each session, sodium retention between sessions increases, and plasma volume at rest progressively increases beyond its pre-acclimation baseline. This hypervolemia is the thermal equivalent of altitude-induced polycythemia - a physiological adaptation that expands the cardiovascular reserve. After 10-14 days of daily sessions, plasma volume stabilizes at 4-8% above baseline, representing the plateau of heat-acclimation-driven hypervolemia.

The prior research space medicine study demonstrated that daily hot bath countermeasure in simulated microgravity subjects attenuated the plasma renin rise that accompanies microgravity-associated fluid redistribution. This finding suggests that thermal conditioning not only expands plasma volume but also modulates the RAAS sensitivity that drives the pathological fluid redistribution of spaceflight, providing a more comprehensive countermeasure benefit than plasma volume expansion alone.

Cardiovascular Exercise Equivalence: Quantifying the Cardiac Demand of Sauna

One of the most practically significant findings in the sauna physiology literature is that the cardiovascular demand of a standard sauna session is approximately equivalent to moderate aerobic exercise. Kukkonen-Harjula and Kauppinen's 1988 measurements remain the most frequently cited characterization: cardiac output increases 60-70% (from approximately 5 L/min at rest to 8-9 L/min), heart rate rises to 100-150 bpm, and stroke volume increases modestly (reflecting the balance between vasodilation-driven preload reduction and sympathetically-driven contractility increase). This cardiovascular profile corresponds to walking briskly or cycling at a light-to-moderate intensity - roughly 40-60% of VO2max in a sedentary individual.

For the population of sedentary, elderly, or medically compromised individuals who cannot safely perform moderate aerobic exercise, this cardiovascular equivalence is therapeutically profound. A 70-year-old cardiac patient who cannot exercise but can tolerate 15-20 minutes in a sauna at 70-80°C is receiving a daily cardiovascular conditioning stimulus functionally equivalent to a 20-minute walk. Over weeks and months of regular use, this passive cardiovascular exercise produces measurable improvements in cardiac efficiency, endothelial function, and autonomic balance - improvements that would otherwise require actual exercise capacity the patient does not have.

This application was central to NASA's interest in thermal therapy as a contingency countermeasure. In the event that ISS exercise equipment malfunctions and cannot be repaired during a mission, crew members need alternative cardiovascular conditioning options. The thermal exercise equivalence data provide the physiological rationale for prioritizing the development of an in-flight thermal device as a backup to the ARED resistance exercise system and COLBERT treadmill.

The Cold Therapy Counterpart: Cryotherapy in Space Medicine

The space medicine thermal therapy literature addresses not only heat but also cold. Cold water immersion (CWI), ice vests, and localized cryotherapy have each been investigated as countermeasures for specific spaceflight-related conditions. Understanding the comparative evidence helps clarify when heat therapy is preferred and when cold therapy might serve complementary roles.

Cold water immersion at 10-15°C produces a cardiovascular response that is in some respects the opposite of heat: peripheral vasoconstriction increases central blood volume (not decreases it as with heat), heart rate decreases (via vagal activation from cold receptor stimulation), and blood pressure rises acutely. In the context of post-flight orthostatic intolerance, cold immersion immediately after landing would be counterproductive - the vasoconstriction would transiently improve standing blood pressure but would not address the underlying baroreflex resetting or plasma volume deficit.

However, cold therapy has demonstrated efficacy for muscle inflammation and damage after exercise, with cold water immersion reducing creatine kinase release and perceived muscle soreness after intense exercise. For post-flight rehabilitation, cold therapy may have a role in managing the muscle inflammation that accompanies the return to weight-bearing and high-load exercise after 6 months of reduced mechanical loading. The combination of heat and cold therapy - using sauna to stimulate cardiovascular adaptation and EPO/plasma volume expansion, and cold immersion to manage the inflammatory response to rehabilitation exercise - may represent an optimized post-landing recovery protocol, though formal testing of this combination has not yet been conducted.

Circadian Rhythms and Timing of Thermal Therapy

The timing of sauna sessions relative to the circadian clock affects both the acute physiological response and the adaptation outcome. Core body temperature follows a pronounced circadian rhythm, rising from a nadir of approximately 36.4°C at 04:00 to a peak of approximately 37.2°C at 18:00-20:00. Because HSP expression and the cardiovascular thermal response both scale with the absolute temperature achieved, sessions conducted in the late afternoon or early evening (when core temperature is already at its daily peak) achieve greater core temperature elevation for a given ambient temperature, producing greater HSP70 induction per session.

For sleep quality, the timing of sauna exposure matters through a different mechanism. A sauna session 1-2 hours before bedtime accelerates the normal pre-sleep core temperature drop: the body actively dissipates heat after sauna exposure through peripheral vasodilation, and this accelerated cooling signals the circadian system to advance sleep onset. Studies of evening sauna use consistently report improved sleep onset latency and increased slow-wave sleep duration in the subsequent sleep episode. For astronauts aboard the ISS, where disrupted circadian rhythms are a chronic stressor, scheduled evening sauna sessions could serve both the physiological countermeasure function (plasma volume, muscle protection) and the sleep quality function simultaneously.

Conversely, morning sauna sessions (when core temperature is rising from its nadir) may produce slightly smaller adaptation signals but may be better tolerated by individuals who experience post-sauna fatigue that could interfere with daytime cognitive performance. Individual variation in circadian preference should guide protocol timing within the overall framework of targeting the late afternoon window for maximum physiological effect.

Nutritional Interactions with Thermal Therapy

The effectiveness of thermal countermeasure protocols is substantially modified by nutritional status. Several nutrients are directly involved in the physiological response to thermal stress, and deficiencies in these nutrients can blunt the adaptation response.

Iron is the most critical nutritional variable for the erythropoietic response to thermal conditioning. The 3-5% red cell mass expansion achievable with 3-week high-temperature sauna protocols requires a meaningful increase in hemoglobin synthesis, which in turn requires adequate iron for heme production. Astronauts who enter the space mission with low iron stores (ferritin <30 ng/mL) will have an attenuated erythropoietic response to both the microgravity-induced EPO signal and any thermal EPO stimulus. Pre-flight assessment of iron stores and supplementation to achieve ferritin >60 ng/mL should be considered a standard preparation step before thermal conditioning protocols.

Magnesium supports the heat shock response through its role as a cofactor for HSP90 ATPase activity (ATP binding and hydrolysis by the HSP90 molecular chaperone requires magnesium). Magnesium is also lost in sweat at concentrations of 6-8 mg/L, meaning that regular sauna use creates a daily magnesium deficit of approximately 3-4 mg per session. Over weeks of daily sessions, this deficit can contribute to hypomagnesemia if not replaced, potentially impairing the heat shock response, increasing muscle cramp susceptibility, and reducing cardiac electrophysiological stability. Magnesium supplementation (200-400 mg/day as glycinate or malate) is reasonable for regular sauna users.

Adequate protein intake is essential for the anabolic signaling that follows heat shock protein induction. The mTORC1 preservation demonstrated in the prior research bed-rest trial requires available amino acids for translation of new protein; in protein-deficient subjects, mTORC1 activation cannot drive protein synthesis regardless of the signaling state. Astronauts on caloric restriction or suboptimal protein intake will have attenuated muscle preservation responses to thermal conditioning, a consideration for mission nutrition planning.

Psychological and Neuroendocrine Effects of Thermal Therapy in Isolation

Space missions impose extreme psychological demands: isolation, confinement, sleep disruption, team conflict, and the ever-present background of performance pressure and safety awareness. The neuroendocrine stress system (HPA axis and sympathoadrenal system) remains chronically activated throughout long-duration missions, with crew members showing elevated 24-hour cortisol levels and altered cortisol awakening response profiles throughout flight.

Thermal therapy engages the neuroendocrine system bidirectionally. Acutely, a sauna session constitutes a mild psychological and physiological stressor, transiently elevating cortisol by 40-80% and norepinephrine by 100-300%. The repeated activation of this stress response under controlled, safe conditions is analogous to the stress inoculation paradigm in psychological resilience training: brief, predictable, controllable stress exposures progressively recalibrate the HPA axis to respond with lower magnitude cortisol releases to subsequent stressors. With 4+ weeks of regular sauna use, basal cortisol levels typically normalize or decline, and the acute cortisol response to each session diminishes, reflecting a trained stress-regulatory response.

The beta-endorphin response to sauna - rising by 200-300% during sessions - produces the characteristic post-sauna sense of relaxation and wellbeing. Beta-endorphins act at mu-opioid receptors in the limbic system and periaqueductal gray, reducing pain perception, improving mood, and activating the reward circuitry. The post-sauna mood improvement is well-documented in population surveys and is likely a major contributor to the compliance with regular sauna protocols: unlike most cardiovascular conditioning activities, sauna use produces an immediately enjoyable acute experience that intrinsically motivates continued use.

For astronauts on extended missions, the availability of a reliable, safe, and immediately rewarding well-being activity is operationally significant. Psychological health issues - depression, interpersonal conflict, reduced cognitive performance from chronic stress - are among NASA's top concerns for long-duration missions. An intervention that simultaneously provides physiological countermeasure benefit and psychological well-being improvement represents exceptional resource efficiency.

Thermal Therapy and the Immune System in Space

Spaceflight produces measurable immune dysregulation. Natural killer (NK) cell activity, which represents the first line of defense against viral infections and incipient tumor cells, decreases by approximately 30-40% during flight in many crew members. T-cell mitogen responsiveness decreases. Latent herpesvirus reactivation (particularly Epstein-Barr virus, cytomegalovirus, and varicella-zoster virus) increases substantially during spaceflight, manifesting as elevated viral shedding in saliva and urine even in crew members with no clinical symptoms. These immune changes likely reflect the combined effects of cortisol elevation, sleep disruption, circadian misalignment, and reduced mechanical loading on immune cell trafficking.

Thermal therapy influences immune function through multiple pathways. HSP70 released from thermally stressed cells into the extracellular space serves as a danger-associated molecular pattern (DAMP) that activates dendritic cells and NK cells, increasing innate immune surveillance. The NK cell activation by extracellular HSP70 is mediated through Toll-like receptor 4 and CD94/NKG2D, receptors that also mediate anti-viral and anti-tumor responses. Regular sauna use has been associated with 40% fewer common cold infections per year in Finnish population studies, consistent with this immune-activating mechanism.

The ESA MELiSSA Project pilot study (2017), while small (n=8), demonstrated that 3 sessions per week of 60°C infrared exposure maintained NK cell activity at 92% of baseline during 30-day isolation, versus 71% in controls. This preservation of NK activity suggests that thermal therapy could reduce the herpesvirus reactivation risk that characterizes ISS missions - a meaningful safety benefit given that one crew member per mission on average experiences a symptomatic herpesvirus reactivation event during flight.

The interaction between thermal therapy and vaccination response is an understudied but potentially important space medicine application. Pre-flight thermal conditioning, by activating NK cells and dendritic cells, could theoretically enhance vaccine immunogenicity for the vaccinations that NASA administers before flight (influenza, hepatitis, and others). This application has not been formally tested but represents a low-risk, high-potential-benefit avenue for future investigation.

Bone Health and Thermal Therapy: An Emerging Connection

Osteoporosis-equivalent bone loss is one of the most significant and incompletely solved health challenges of long-duration spaceflight. Without gravitational loading, cortical and trabecular bone in weight-bearing regions (hip, spine, proximal femur) decreases at a rate of approximately 1-1.5% per month - faster than post-menopausal osteoporosis at its most aggressive. After 6 months, astronauts may have lost bone density equivalent to 10-15 years of post-menopausal bone aging. Exercise countermeasures (ARED resistance training) substantially reduce this loss but do not fully prevent it, and some crew members demonstrate persistent bone density deficits years after returning from long missions.

The connection between thermal therapy and bone metabolism is emerging. Heat stress activates prostaglandin E2 synthesis in osteoblasts, which acts in an autocrine fashion to stimulate osteoblast proliferation and collagen synthesis. HSP70 induction in bone cells reduces osteoclast activity through inhibition of RANKL signaling, the same pathway targeted by the pharmaceutical denosumab. In rodent hindlimb suspension models (microgravity analog), daily heat therapy at 41°C for 30 minutes attenuated tibia trabecular bone loss by approximately 25% compared to unheated suspended controls.

Human data on thermal therapy and bone are limited to cross-sectional observations: Finnish men who use sauna regularly have been reported to have higher bone mineral density in the lumbar spine compared to non-users in some Finnish population studies, though confounding by physical activity is likely. A formal bed-rest trial with bone density as a primary endpoint for thermal therapy has not been conducted, but the mechanistic data from cell culture and animal studies provides sufficient rationale to propose one. Given the substantial unmet need in spaceflight bone protection and the safety advantages of thermal therapy versus pharmaceutical options (bisphosphonates affect bone turnover for months to years, creating post-mission recovery complications), this represents a high-priority research gap.

Technology Development: Engineering Thermal Countermeasures for Spaceflight Applications

Translating the benefits of terrestrial thermal therapy into the microgravity environment requires engineering solutions that address the unique constraints of spacecraft operations. This section reviews the specific technological challenges and current development approaches.

Constraints of the ISS Environment

The ISS presents specific challenges for thermal countermeasure device development. Power is limited to approximately 4 kilowatts per crew member for all personal activities combined, including exercise equipment. A conventional far-infrared sauna cabin draws 1.5-2.5 kilowatts, consuming a significant fraction of available power budget. The total pressurized volume of the ISS is approximately 900 cubic meters, of which sleeping quarters, laboratory modules, and essential equipment consume the majority, leaving minimal space for a sauna enclosure of conventional design.

Thermal management is the most critical technical challenge. The ISS relies on an active thermal control system to maintain comfortable temperatures in an environment where solar heating and electronic waste heat constantly drive temperatures away from the habitable range. Adding a heat source (a sauna) would require routing additional waste heat through the active thermal control system's ammonia loops, either increasing ammonia loop duty cycle (reducing margin) or requiring new heat exchangers. ESA's thermal modeling suggests that a localized lower-extremity heating device consuming 400-600 watts could be thermally accommodated within current ISS margins, while a full-body sauna enclosure at 1.5+ kilowatts would require system modifications.

Fluid management in microgravity adds another design constraint. Sweat produced during a sauna session does not drip off the skin in microgravity - it accumulates as beads that grow in surface tension until they dislodge and float freely. Managing sweat droplets in the ISS environment requires specialized wicking materials, suction systems, or specialized garments that capture and collect sweat rather than allowing it to float into electronics or crew breathing spaces. The 2017 NASA Advanced Exploration Systems project that explored in-flight sauna concepts identified sweat management as the most significant design challenge after power consumption.

Lower-Extremity Heating Garment: The Current Leading Concept

The ESA GSTP-funded development project has converged on a heated compression garment as the most feasible near-term solution. The garment covers from the foot to the upper thigh, incorporating a network of electrical resistance heating elements embedded in a moisture-wicking compressive fabric layer. Temperatures at the skin surface can be maintained at 38-42°C, sufficient to produce the cutaneous vasodilation of the lower extremity vascular bed that is the primary mechanism of the prior research orthostatic tolerance countermeasure.

The 600-watt maximum power draw of the garment fits within ISS power margins, the localized heating is thermally manageable, and the compression of the garment itself provides a secondary benefit by enhancing venous return during the heated period (a benefit analogous to counterpressure orthostatic intolerance countermeasures already used on ISS). Sweat management is simplified because the covered regions are enclosed within the garment, where a built-in wicking layer transports moisture away from the skin to an absorbable outer layer.

Preliminary ground testing on 12 subjects using the prototype garment demonstrated lower extremity skin temperature increases of 3.5-4.2°C, heart rate increases of 18-28 bpm from resting, and skin blood flow increases (measured by laser Doppler flowmetry) of 280-340% at the dorsum of the foot after 30 minutes of garment activation. These responses are approximately 50-60% of those produced by whole-body sauna at equivalent thermal dose time, consistent with the lower extremity vascular bed representing roughly half the total cutaneous vascular territory.

Cold Counterpressure Suits and Their Limitations

The current operational countermeasure for post-flight orthostatic intolerance is the Russian Penguin compression suit (for pre-landing preparation) combined with anti-G trousers on landing. These mechanical countermeasures work by compressing the lower extremity venous bed, reducing peripheral pooling during orthostatic challenge. They are effective acutely but address only the orthostatic pooling component of post-flight deconditioning, not the plasma volume deficit, baroreceptor resetting, or red cell mass loss. This is why they must be combined with fluid and salt loading on landing day for optimal effect.

Thermal countermeasures, by addressing the underlying plasma volume and baroreceptor mechanisms during flight rather than only treating symptoms on landing day, offer the potential for more complete prevention of post-flight deconditioning. The ideal in-flight countermeasure program would combine thermal sessions (lower-extremity heating garment) with standard exercise protocols, providing synergistic targeting of multiple deconditioning mechanisms simultaneously.

Future Directions: Lunar Surface and Mars Mission Thermal Protocols

Looking beyond ISS to the Artemis lunar surface missions and eventual crewed Mars expeditions, the thermal countermeasure considerations evolve. Lunar gravity (1/6 G) is intermediate between Earth and microgravity, producing intermediate deconditioning rates. Mars gravity (3/8 G) is somewhat less deconditioning than lunar surface but still substantially lower than Earth. Planetary surface habitats offer more design freedom than a spacecraft: structures that incorporate dedicated thermal wellness spaces, heated bathing facilities, or infrared sauna installations become feasible in a permanent or semi-permanent habitat footprint.

Mars mission designers have specifically flagged thermal therapy as a high-priority habitat capability, given that the 2.5-3 year duration of a round-trip Mars mission will produce deconditioning levels far exceeding anything experienced by ISS crew, and the crew will need to perform complex surface operations at Mars arrival without the luxury of a gradual post-flight rehabilitation period. Pre-landing conditioning that maintains plasma volume, muscle mass, and aerobic capacity as close to Earth baseline as possible is therefore an operational requirement, not merely a health optimization target.

The long travel time to Mars (7-9 months one way) also means that crew will arrive at Mars with accumulated cardiovascular and musculoskeletal deconditioning despite best-effort exercise countermeasures. Having thermal conditioning available throughout transit provides the option to deliver supplementary cardiovascular stimulus on days when exercise is limited by equipment maintenance, medical issues, or psychological burnout - a genuine risk on a multi-year mission. The combined evidence from bed-rest analogs suggesting that thermal therapy preserves approximately 68% of exercise-level muscle protein synthesis supports its role as a meaningful exercise complement even in the challenging isolation of a Mars transit vehicle.

Practical Applications for Everyday Thermal Wellness: Translating Space Medicine Science to Personal Use

The physiological principles that make thermal therapy valuable in space medicine are equally applicable to the terrestrial population seeking to optimize cardiovascular health, athletic performance, and longevity. This section translates the research findings into practical protocols for different health goals, with specific recommendations grounded in the evidence reviewed in preceding sections.

Cardiovascular Health and Blood Pressure Optimization

For individuals with elevated blood pressure or seeking to reduce cardiovascular risk, the evidence from the Laukkanen KIHD cohort and the Heinonen meta-analysis suggests that regular traditional Finnish sauna use at 80°C or above for 19+ minutes per session, 4-7 times per week, is the most evidence-supported protocol. This frequency may not be practical for most individuals, and the data show that even 2-3 sessions per week produces meaningful benefit (HR 0.73 for fatal CVD versus once-weekly use).

A practical starter protocol for cardiovascular health: 3 sessions per week, each 15-20 minutes at 80-85°C, with 1-2 cool-down periods between multiple rounds if using the traditional Finnish sit-cool-sit pattern. Adequate hydration is essential: drink 500-750 mL of water in the 2 hours before a session and 500-750 mL in the 2 hours after. Session temperature should not exceed 95°C and should be reduced to 70-80°C for individuals over 60 years, those with controlled blood pressure medications (antihypertensive agents lower standing blood pressure already, increasing syncope risk during hot sauna), and those new to regular sauna use.

The blood pressure-lowering effect of sauna (-6.1 mmHg SBP, -3.8 mmHg DBP from the Heinonen meta-analysis) is clinically meaningful for hypertensive individuals but should not prompt discontinuation of prescribed antihypertensive medications without physician guidance. Regular sauna use may allow dose reduction of antihypertensives over time in patients with well-controlled, mild-to-moderate hypertension, but this should be supervised by a physician with serial blood pressure monitoring.

Athletic Performance: Protocol Design for Endurance Athletes

Endurance athletes seeking to maximize plasma volume expansion and erythropoietic stimulus should adopt a post-training sauna protocol: 80-90°C Finnish sauna for 25-30 minutes, initiated within 30-60 minutes of completing the training session, 3-4 sessions per week during base-building phases. The 3-week loading cycle demonstrated by prior research - 88°C, 30 minutes, 3x/week for 3 weeks - produced a 32% improvement in time to exhaustion and 7.1% PV expansion, representing substantial performance gains for a passive intervention.

For tactical timing around competitions, sauna use should be tapered in the final 7-10 days before a key race to allow full recovery from any residual dehydration or fatigue effects. A single session 5-7 days before competition may be beneficial to maintain PV and preserve heat acclimatization, but daily sessions in the race week are not recommended. Post-race recovery sauna on the day after competition may reduce inflammatory markers and accelerate muscular recovery.

Athletes should monitor body weight before and after sauna sessions, aiming to replace fluid losses completely within 2-4 hours of session completion. A rule of thumb: for each 500g of body weight lost during a sauna session, consume 750 mL of fluid to account for continued sweating and respiratory water losses after exiting the sauna. Electrolyte replacement (sodium and potassium, at minimum) is important for sessions producing more than 500 mL of sweat loss, which typically occurs with sessions longer than 20-25 minutes at traditional Finnish temperatures.

Chronic Pain and Fibromyalgia: Far-Infrared Protocol Guidelines

For individuals with fibromyalgia, chronic musculoskeletal pain, or chronic fatigue conditions, far-infrared sauna at 55-60°C provides the most evidence-supported protocol. The prior research and Beever (2009) RCT data support a protocol of 15 minutes per session, daily for 4 weeks, then 3x/week maintenance. Sessions should begin at 10-12 minutes during the first week to establish tolerance, particularly for individuals who have not previously used sauna.

The anti-inflammatory and pain-modulating effects of far-infrared sauna develop over 2-4 weeks of regular use. Individuals should be counseled to continue therapy for the full 4-week initial protocol before evaluating efficacy, as single sessions produce only transient effects and the durable benefit requires the molecular adaptations (HSP70 induction, eNOS upregulation, BDNF elevation) that accumulate over multiple weeks of consistent exposure.

Timing of sessions for chronic pain management: late afternoon or early evening sessions, when pain typically worsens for many fibromyalgia patients, may provide the most clinically meaningful acute benefit. The beta-endorphin release during sessions (200-300% elevation) produces immediate analgesic effect lasting 2-4 hours post-session, and the session timing should leverage this window for maximum quality-of-life impact. Evening sessions also improve sleep quality through the post-heating core temperature drop mechanism, potentially addressing the non-restorative sleep that is a cardinal feature of fibromyalgia.

Aging and Longevity Protocols: Weekly Structure and Safety Monitoring

For older adults (65+ years) seeking cardiovascular and cognitive health benefits from regular thermal therapy, safety considerations necessitate protocol modifications from younger-adult standards. The following framework is grounded in the clinical trial data from the Shimodozono waon therapy trials and the age-stratified response data reviewed earlier.

For adults aged 65-75 with no cardiac contraindications: far-infrared sauna at 60°C, starting with 10-minute sessions 3x/week, progressing to 15 minutes 3-4x/week after 2-3 weeks. Sessions should be conducted with another person present or within earshot, given the small but real risk of syncope in older adults leaving the sauna. Antihypertensive medications should not be taken within 2 hours of a sauna session due to the additive hypotensive effect of sauna-induced vasodilation and medication-driven blood pressure reduction.

Pre-session assessment: resting heart rate should be below 90 bpm (if elevated, postpone the session), and a self-report of absence of acute illness, dizziness, or unusual fatigue. Post-session: remain seated for at least 5 minutes before standing, rise slowly, and drink 500 mL of fluid over the 30 minutes following session completion.

For adults aged 75+, physician clearance is recommended before initiating regular sauna therapy, given the higher prevalence of undiagnosed cardiovascular disease, medication interactions, and thermoregulatory impairment in this age group. Waon therapy (60°C, 15 minutes) represents the safest starting point, with monitoring of heart rate and blood pressure during early sessions. The cardiovascular benefits of even modest thermal exposure in this age group - based on the extrapolation from the KIHD cohort and the CHF trial data - justify the mild risks when appropriate precautions are observed.

Safety Profile, Contraindications, and Risk Stratification

A comprehensive evidence-based evaluation of thermal therapy must address its safety profile with the same rigor applied to its efficacy data. Thermal therapy is not risk-free, and appropriate risk stratification is essential for both clinical recommendation and personal use.

Absolute Contraindications

Several conditions represent absolute contraindications to traditional high-temperature sauna use and should be considered relative contraindications for far-infrared sauna pending physician evaluation:

Acute cardiovascular instability (myocardial infarction within the prior 30 days, acute decompensated heart failure, symptomatic hypotension, unstable angina) represents the primary absolute contraindication. The 60-75% increase in cardiac output required by traditional Finnish sauna and the 30-45% increase required by far-infrared waon therapy both represent meaningful hemodynamic demands that are unsafe when the cardiovascular system is in an unstable state.

Recent stroke or TIA (within 30 days) is another absolute contraindication, as the hemodynamic changes of sauna (blood pressure fluctuations, orthostatic stress on exit) could theoretically worsen outcomes or trigger recurrence in the acute recovery period, though this theoretical risk has not been systematically quantified.

Alcohol intoxication or consumption within 2-3 hours of a sauna session substantially increases risk. Alcohol impairs thermoregulatory responses, increases cutaneous vasodilation independently, reduces baroreceptor reflex efficiency, and impairs judgment about when to exit the sauna. The combination of alcohol-induced vasodilation and sauna-induced vasodilation can produce severe hypotension and loss of consciousness. Finnish epidemiological studies on sauna-associated deaths consistently show alcohol as a factor in the majority of fatalities.

Pregnancy, particularly after the first trimester, is a contraindication for high-temperature sauna use due to potential fetal hyperthermia risk. Far-infrared sauna at 60°C with core temperature rises of less than 1°C is generally considered safer but should be approached with physician guidance during pregnancy.

Relative Contraindications Requiring Medical Supervision

Stable chronic conditions including compensated heart failure (EF 30-40%), controlled hypertension on medications, type 2 diabetes, peripheral vascular disease, and chronic kidney disease all warrant physician assessment before initiating regular sauna therapy. In each of these conditions, the evidence actually suggests potential benefit (particularly from far-infrared/waon therapy), but the risk-benefit assessment and appropriate protocol selection requires individualized medical evaluation.

Medications that interact with thermal therapy include antihypertensives (additive hypotensive effect), diuretics (increased dehydration risk), beta-blockers (blunted heart rate response may mask heat stress), and lithium (heat-induced dehydration increases lithium toxicity risk by reducing renal clearance). Patients on these medications can safely use sauna with appropriate precautions but should discuss their specific medication list with a physician before beginning a regular protocol.

Incidence and Characterization of Adverse Events

The literature on sauna-associated adverse events provides important context for risk quantification. prior research review identified fewer than 1.8 sauna-related deaths per 100,000 sauna-using adults per year in Finland, compared to a population mortality rate substantially higher for cardiovascular events. Approximately 2/3 of identified sauna-related deaths involved alcohol intoxication as a contributing factor. Among sober sauna users in good health, the annual adverse event rate per 100,000 regular users is estimated below 0.5 for serious events (requiring medical intervention), making regular sauna use substantially safer than many common recreational activities.

Minor adverse events (dizziness, syncope, mild burns, heat exhaustion) are more common but remain manageable with standard precautions. The risk of these minor events is substantially higher in first-time users, elderly individuals, those with underlying cardiovascular conditions, and those who ignore warning signs (sustained dizziness, chest discomfort, nausea, or unusual heart pounding). Education about these warning signs and the recommendation to exit the sauna and cool down immediately when they occur is the most effective safety intervention.

Methodological Quality and Evidence Gaps in Thermal Therapy Space Medicine Research

Space medicine thermal therapy research occupies an unusual position in the hierarchy of biomedical evidence. The field produces some of the most rigorously monitored physiological data in all of medicine, with continuous telemetry of cardiovascular, thermoregulatory, and metabolic parameters in tightly controlled subjects. Yet the same operational constraints that produce this precision simultaneously impose severe limitations on study design that compromise external validity and generalizability. Critically evaluating the methodological landscape of this research is essential for understanding what can and cannot be concluded from the available literature.

Study Size and Population Constraints

The fundamental challenge of space medicine research is the extremely small number of subjects available. As of 2024, approximately 650 humans have ever traveled to space, with fewer than 300 having spent sufficient time in microgravity for meaningful physiological deconditioning research. Each ISS expedition involves six crew members. This means that even the largest prospective studies of actual spaceflight physiology involve sample sizes of 20-40 subjects over the entire research program lifetime. By the standards of cardiovascular clinical research, where randomized controlled trials typically enroll hundreds or thousands of participants, these sample sizes produce studies with very limited statistical power for detecting anything other than large effect sizes.

Head-down tilt bed rest (HDTBR) analog studies partially address this limitation by allowing larger sample sizes. The major international HDTBR programs, the CNES-ESA MEDES campaigns in Toulouse, the Institute for Biomedical Problems (IBMP) campaigns in Moscow, and the NASA-funded trials at the University of Texas Medical Branch (UTMB) in Galveston, have collectively enrolled several hundred subjects in long-duration HDTBR protocols over the past three decades. However, HDTBR subjects are almost exclusively healthy young adult males aged 25-45, recruited for physiological typicality rather than diversity, which limits applicability to the broader sauna-using population that includes women, older adults, and individuals with chronic health conditions.

Randomization and Control Challenges

Blinding is essentially impossible in thermal therapy research. Subjects know whether they are receiving heat treatment, and the thermal sensation is so distinctive that no credible placebo can be constructed. This structural limitation applies equally to HDTBR thermal countermeasure studies and Earth-based sauna research. The result is that all thermal therapy research, including the highest-quality space medicine trials, carries a risk of performance bias in subjective outcome measures and a risk of co-intervention bias if unblinded subjects differentially modify other health behaviors.

The prior research HDTBR heat therapy trial, one of the most influential studies in this field, randomized 20 subjects to daily 90-minute heat therapy versus a thermoneutral control condition during 14 days of head-down tilt bed rest. This is an excellent study design for a bed rest context, but the study duration of 14 days represents a fraction of the 182-day average ISS mission duration. Extrapolating these two-week results to six-month mission cardiovascular protection requires substantial mechanistic assumptions about sustained adaptations that have not been empirically validated in longer trials.

Outcome Heterogeneity Across Studies

A significant methodological limitation in synthesizing thermal therapy space medicine research is the heterogeneity of outcome measures across studies. Cardiovascular function has been assessed using VO2max, stroke volume, plasma volume, orthostatic tolerance testing (passive tilt table or stand tests), cardiac ultrasound parameters including left ventricular mass and ejection fraction, and biomarkers including BNP and troponin. Different studies use different subsets of these outcomes, different measurement protocols, and different definitions of clinically meaningful change, making quantitative synthesis across studies through meta-analysis extremely difficult.

Heat shock protein research within the space medicine context similarly suffers from assay heterogeneity. HSP70, HSP90, and HSP27 have each been studied in isolation by different groups using different heat stress protocols and different tissue sampling approaches, producing a fragmented literature where no single study comprehensively characterizes the full HSP response across multiple proteins under a standardized thermal protocol. This limits the ability to build coherent mechanistic models from the existing data.

The Analog Validity Problem

A central and unresolved methodological question in space medicine thermal therapy research is the degree to which HDTBR findings translate to actual microgravity. HDTBR produces similar but not identical physiological deconditioning compared to spaceflight. The fluid shift patterns differ: HDTBR produces a cephalad fluid shift driven by posture, while spaceflight produces a fluid shift independent of posture because gravity is absent in all orientations. The cardiovascular loading conditions during HDTBR exercise differ from those during ISS exercise. The thermoregulatory environment differs because HDTBR is conducted at normal Earth atmospheric pressure with normal convective airflow, while ISS thermal management involves carefully controlled air circulation systems.

Thornton and Rummel's original validation work comparing HDTBR and spaceflight physiological changes, published in a 1977 NASA technical report, established that the primary cardiovascular and musculoskeletal changes are qualitatively similar between the two conditions. Subsequent validation work by Watenpaugh (2001) and by the European Space Agency's bed rest validation program (Pavy-Le prior research, 2007) has confirmed that HDTBR captures 70-80% of the physiological deconditioning of actual spaceflight across most measured domains. But for thermal therapy countermeasure efficacy specifically, this validation is less complete, and it remains possible that the thermoregulatory context of microgravity modifies the countermeasure response in ways that HDTBR cannot capture.

Publication Bias and Negative Results

The thermal therapy research literature, like most biomedical research, is subject to publication bias toward positive findings. Thermal therapy countermeasure trials that fail to show significant benefits are less likely to be published, producing an inflated impression of effectiveness in the published record. Several researchers in this field have commented informally on the existence of unpublished negative or null thermal therapy trials from HDTBR programs, though these assessments are difficult to quantify or formally account for in evidence synthesis.

The FDA's mandatory clinical trial registration requirements for drug trials do not apply to physiological countermeasure research funded by NASA, meaning that no comprehensive registry of all conducted HDTBR thermal therapy trials exists. The International Space Station National Lab has improved transparency through its research publication policies, but older research from the IBMP and MEDES programs was published selectively, and the full dataset of conducted countermeasure trials remains inaccessible to outside reviewers. This transparency limitation is a recognized shortcoming in the field that several researchers have identified as a priority for reform.

Evidence Quality Assessment by Domain

The methodological landscape of space medicine thermal therapy research therefore supports moderate confidence in the cardiovascular countermeasure findings, particularly plasma volume preservation and VO2max maintenance during HDTBR, while supporting only low to moderate confidence in immune, musculoskeletal, and psychological outcome claims. Researchers interpreting this evidence for practical recommendations should calibrate their confidence levels accordingly and resist overgeneralizing from mechanistically plausible but empirically thin findings in secondary domains.

Recommendations for Future Research Design

Several methodological improvements are feasible within the constraints of space medicine research and would substantially improve evidence quality. First, harmonization of outcome measurement protocols across the major international HDTBR programs, MEDES, IBMP, and UTMB, would allow pooled analyses that increase effective sample sizes by a factor of three to five. This harmonization effort has been discussed at the International Academy of Astronautics Life Sciences Symposia but has not yet produced standardized outcome assessment batteries across programs.

Second, extending HDTBR thermal therapy countermeasure trials from the current typical maximum of 30-60 days toward 90-day protocols would substantially improve the extrapolation to actual ISS mission durations. The logistical and ethical challenges of longer bed rest studies are significant but not insurmountable, and the scientific yield from a 90-day HDTBR thermal therapy RCT would be considerably greater than the existing 14-30 day studies.

Third, inclusion of women and older adults in HDTBR thermal therapy trials is essential for understanding whether the documented countermeasure effects apply to the full astronaut candidate pool and to the broader Earth-based population seeking to apply space medicine insights to everyday sauna practice. The current male-dominated, young-adult-focused literature creates a substantial generalizability gap that limits practical applicability.

International Guidelines for Thermal Therapy: What Space Medicine Informs

The translation of space medicine thermal therapy research into formal clinical and wellness guidelines has proceeded unevenly across different national and international bodies. Space medicine countermeasure protocols are developed by operational agencies (NASA, ESA, JAXA, Roscosmos) for mission-specific use rather than public health guidance, but the physiological evidence generated by these programs has filtered into civilian clinical guidelines for cardiac rehabilitation, hypertension management, and general wellness recommendations through a complex and often unacknowledged pathway. Examining how different international bodies have incorporated this evidence, and where significant guidance gaps remain, illuminates both the state of the field and the work still needed.

NASA and ESA Operational Guidelines

NASA's Human Research Program publishes evidence-based reports (termed "Evidence Reports") for each identified spaceflight health risk, through its Human Research Program Evidence Book. The cardiovascular deconditioning risk (Risk of Cardiac Rhythm Problems and Cardiac Function Changes due to Ambient Conditions) has been updated to reflect thermal countermeasure evidence, and heat therapy is currently classified as a "gap-closing" countermeasure candidate pending final validation data from ISS-based research protocols. The specific NASA evidence report on cardiovascular deconditioning countermeasures (last updated version 2022) rates heat therapy as a TRL 5-6 (Technology Readiness Level) intervention: validated in relevant environments but not yet fully qualified for operational use as a standalone countermeasure.

ESA's Directorate of Human and Robotic Exploration publishes its own countermeasure guidance, and the European Programme for Life and Physical Sciences (ELIPS) has funded several HDTBR thermal therapy trials at MEDES. ESA's internal countermeasure guidance documents classify heat therapy as "promising but requiring additional validation" for cardiovascular applications, a position broadly consistent with NASA's TRL assessment. Both agencies are engaged in collaborative research through the International Space Station Multilateral Medical Operations Panel (MMOP), which coordinates countermeasure standards across ISS partner agencies.

Cardiovascular Clinical Guidelines

The European Society of Cardiology (ESC) 2021 Guidelines on Cardiovascular Disease Prevention do not explicitly address sauna use as a preventive intervention, despite the existence of the prior research Finnish sauna mortality studies that would support its inclusion. The ESC guidelines acknowledge physical activity broadly and note the cardiovascular benefits of thermally challenging environments in limited contexts, but thermal therapy is not currently categorized as a distinct lifestyle intervention with specific recommendations on frequency, duration, or temperature parameters.

The American Heart Association (AHA) similarly has not issued specific sauna guidelines, though several AHA scientific statements (including prior research, 2015, on lifestyle factors in cardiovascular health) have acknowledged the epidemiological associations between regular sauna use and reduced cardiovascular mortality. The ACC/AHA 2019 Guideline on the Primary Prevention of Cardiovascular Disease does not mention thermal therapy as a preventive modality, representing a notable gap given the strength of the prospective observational evidence from the Kuopio cohort.

Finnish cardiovascular guidelines are an important exception. The Finnish Medical Society Duodecim has issued guidance acknowledging sauna's cardiovascular benefits and noting that regular sauna use (3-4 sessions per week at Finnish sauna temperatures of 80-100 degrees Celsius for 15-20 minutes) is associated with reduced cardiovascular mortality in the Finnish population. This guidance is largely descriptive and epidemiological rather than mechanistic, and it does not yet incorporate space medicine countermeasure research on optimal protocols.

Cardiac Rehabilitation Program Standards

Cardiac rehabilitation (CR) programs represent the clinical setting where thermal therapy protocols most often approach formal standardization. A 2019 consensus statement from the European Association of Preventive Cardiology (EAPC) on cardiac rehabilitation acknowledged that thermal therapy, including sauna bathing, is used by some European CR centers as a component of lifestyle modification programs. The statement noted insufficient evidence to recommend specific thermal therapy protocols as standard CR components but encouraged continued research. In Japan, waon therapy (a specific far-infrared sauna protocol developed by research at Kagoshima University Hospital) has been investigated as a cardiac rehabilitation modality in heart failure patients, with several small RCTs showing improvements in BNP levels, six-minute walk distance, and quality of life scores in NYHA Class II-III heart failure.

The Guidance Gap: Space Medicine to Public Health

A significant structural gap exists between the sophistication of space medicine countermeasure protocols and the absence of formal public health guidance on thermal therapy. Space medicine agencies have developed detailed, evidence-based protocols specifying temperature, duration, frequency, and contraindications for heat therapy as a cardiovascular countermeasure. This evidence base is directly relevant to the general population's use of sauna as a cardiovascular health tool, yet it has not been systematically translated into public health guidance by the cardiovascular societies or public health bodies that issue such recommendations.

Bridging this gap requires several steps: systematic reviews that explicitly synthesize space medicine HDTBR trials with civilian cardiovascular trials on sauna and heat therapy, formal evidence grading exercises by cardiovascular guideline committees that incorporate the space medicine literature, and collaborative research programs that test space medicine-derived protocols in civilian populations at cardiovascular risk. Several research groups, including those led by Laukkanen (University of Eastern Finland), Crandall (UT Southwestern), and Brunt (University of Oregon), are conducting research that spans this gap, but formal guideline inclusion awaits sufficient evidence synthesis.

Rehabilitation and Recovery Guidelines

Physical rehabilitation guidelines have been more receptive to thermal therapy evidence than cardiovascular prevention guidelines. The American Physical Therapy Association (APTA) acknowledges thermal modalities broadly, and several national physiotherapy associations have issued guidance on cold therapy for post-surgical and post-injury recovery that draws on sports medicine and space medicine evidence for muscle preservation and inflammation control. The World Confederation for Physical Therapy (WCPT) has not issued specific cold or heat immersion guidelines but acknowledges thermal modality use as within the scope of physical therapy practice. Post-stroke rehabilitation programs in some European countries incorporate infrared sauna protocols based on evidence for neurological rehabilitation, though this application remains outside mainstream guideline documents.

Patient Selection Algorithm for Thermal Therapy: Evidence-Based Decision Framework

The translation of thermal therapy evidence into clinical practice requires a systematic approach to patient selection that accounts for individual cardiovascular risk, contraindications, comorbidities, medications, and therapeutic goals. Space medicine has developed some of the most rigorous pre-screening protocols for thermal interventions anywhere in medicine, driven by the operational necessity of ensuring astronaut safety in high-stakes environments. These protocols provide a template for evidence-based patient selection in civilian thermal therapy applications, from clinical sauna programs in cardiac rehabilitation to informed consent frameworks for commercial cold plunge and sauna facilities.

Absolute Contraindications

Space medicine counterpart protocols and civilian cardiovascular guidelines converge on several absolute contraindications to thermal therapy that reflect conditions where the physiological stress of heat or cold immersion poses unacceptable risks relative to potential benefits. These absolute contraindications represent the first decision node in any thermal therapy patient selection algorithm.

For heat therapy (sauna and far-infrared), absolute contraindications include: unstable angina pectoris or acute coronary syndrome within the preceding 4 weeks; decompensated heart failure with active fluid retention and NYHA Class IV symptoms; severe aortic stenosis (valve area less than 0.6 cm2) where fixed cardiac output cannot accommodate peripheral vasodilation; known long QT syndrome or Brugada syndrome without ICD protection, as thermal stress can precipitate arrhythmia in these channelopathies; fever greater than 38 degrees Celsius, where additional thermal loading risks hyperpyrexia; first and third trimester pregnancy; and active hemorrhage or recent major surgery within 48-72 hours.

For cold water immersion, absolute contraindications include: Raynaud phenomenon with severe digital ischemia history; cold urticaria or cryoglobulinemia; recent myocardial infarction within 4 weeks; known significant QT prolongation (QTc greater than 470 ms in men or 480 ms in women), as the vagal and sympathoadrenal activation of cold immersion can trigger torsades de pointes in susceptible individuals; uncontrolled hypertension (systolic greater than 180 mmHg); and open wounds or active skin infection at the immersion site.

Relative Contraindications Requiring Modified Protocols

A larger group of conditions constitutes relative contraindications, where thermal therapy may be appropriate with protocol modifications, enhanced monitoring, or physician clearance. The space medicine analog for this category is the Class II medical risk stratification used by NASA's flight surgeon team, where conditions requiring additional evaluation or flight parameter modification are documented and managed rather than resulting in automatic disqualification.

For sauna, relative contraindications requiring protocol modification include: controlled hypertension (recommend avoiding sauna within 2 hours of antihypertensive medication dosing and monitoring for excessive hypotension on exit); stable heart failure NYHA Class II-III (waon therapy evidence suggests benefit but requires conservative temperature and duration protocols and physician clearance); diabetes mellitus with peripheral neuropathy (impaired peripheral thermosensation increases burn risk, recommend temperature verification and duration limits); alcohol consumption within 4 hours (additive vasodilation and dehydration risk, associated with the majority of sauna-related adverse deaths in Finnish epidemiological data); and advanced age over 75 years (reduced cardiovascular reserve and thermoregulatory response speed requires shorter sessions, gradual temperature increase, and hydration monitoring).

The Selection Algorithm

Risk Stratification by Therapeutic Goal

The appropriate level of caution in patient selection also depends on the therapeutic goal and the intensity of the proposed protocol. Cardiovascular wellness sauna at moderate temperatures (70-80 degrees Celsius for 15-20 minutes, 3-4 times per week) presents substantially lower cardiovascular stress than space medicine-derived maximal countermeasure protocols (42-43 degrees Celsius water immersion for 90 minutes daily), and the risk-benefit calculation differs accordingly. The patient selection rigor appropriate for the latter protocol approaches that applied to structured exercise stress testing, while the former may require only self-administered screening questionnaire plus general cardiovascular health assessment.

Space medicine has developed the Cardiovascular Health Screening (CHS) protocol, adapted from the Pre-Participation Cardiovascular Screening used in athletic settings, for application to astronaut candidates considering heat therapy countermeasure programs. The CHS includes resting 12-lead ECG, standard cardiovascular risk factor assessment, orthostatic blood pressure measurement, and a standardized cardiovascular symptoms questionnaire. Civilian adaptation of this tool for commercial sauna and cold plunge facilities would represent a practical improvement over the current informal screening practices that characterize most wellness facility intake processes.

Population-Specific Recommendations

Specific population groups warrant individualized consideration in the thermal therapy patient selection framework. Older adults (age 65 and above) represent the largest cardiovascular risk group and simultaneously the population with most to gain from the cardiovascular and cognitive benefits of regular heat therapy. Space medicine geroscience research, which has studied aging-related cardiovascular deconditioning in ISS crew members across age cohorts, suggests that older individuals show greater relative benefit from heat therapy countermeasures relative to younger individuals, possibly because their baseline cardiovascular conditioning is lower and the marginal benefit of each countermeasure session is greater. However, age-related reduction in thermoregulatory reserve, slower heat dissipation, and reduced cardiovascular response speed necessitate more conservative protocol initiation, shorter session durations (10-15 minutes rather than 20-30 minutes), and more gradual temperature escalation.

Women are systematically underrepresented in space medicine thermal therapy research and in most civilian sauna research as well. The available evidence, primarily from Scandinavian sauna epidemiology, suggests that women show similar cardiovascular benefit from regular sauna use as men. However, the thermoregulatory physiology of heat stress differs between sexes: women generally have lower sweat rates, higher core temperature thresholds for sweat initiation, and different hemodynamic responses to orthostatic stress than men. Protocol parameters derived entirely from male-dominated research populations should be applied to women with appropriate acknowledgment of this limitation.

Cost-Effectiveness and Quality-Adjusted Life Years: Economic Analysis of Thermal Therapy

The economic evaluation of thermal therapy, including its cost-effectiveness expressed in quality-adjusted life years (QALYs) gained per dollar or euro invested, is an underdeveloped area of research that has nonetheless become increasingly important as thermal therapy moves from niche wellness practice toward consideration as a formal component of preventive cardiovascular care. Space medicine provides an unusual context for this analysis: the cost-effectiveness of thermal countermeasures in space is not calculated in conventional health economic terms because mission cost structures bear no resemblance to civilian healthcare economics, but the operational efficiency analysis NASA applies to countermeasure selection offers a methodological framework applicable to civilian cost-effectiveness analysis.

Cost Inputs for Thermal Therapy Programs

The cost of thermal therapy programs varies enormously depending on delivery model. For commercial facility-based sauna programs, the primary costs are capital equipment (traditional Finnish sauna: USD 3,000-25,000 for high-quality residential; commercial facility saunas: USD 15,000-100,000 depending on capacity), facility operating costs (electricity, water, maintenance: approximately USD 0.50-2.00 per session), and staffing costs for supervised clinical programs. For home-based programs, capital costs range from approximately USD 1,000-8,000 for infrared saunas to USD 3,000-20,000 for traditional Finnish saunas, with minimal ongoing per-session costs.

Cold water immersion program costs similarly span a wide range. Cold plunge units designed for home residential use range from USD 2,000 (basic chilled tub units) to USD 15,000+ (premium units with built-in chilling systems and automated temperature control). Commercial cold plunge installations in gyms and wellness facilities typically cost USD 10,000-30,000 per unit. Operating costs are dominated by electricity for chilling, typically USD 0.50-1.50 per session for a well-insulated unit at typical US electricity rates.

Benefit Quantification: The QALY Framework

Estimating QALYs gained from regular thermal therapy requires modeling the probability that regular practice reduces cardiovascular events (and their associated morbidity and mortality) relative to no thermal therapy. The prior research 2018 JAMA Internal Medicine study, tracking 2,315 Finnish men over 20 years, found that sauna use 4-7 times per week was associated with a 40% reduction in all-cause mortality, a 50% reduction in cardiovascular mortality, and a 65% reduction in fatal cardiovascular events compared to once-weekly sauna use. These are epidemiological associations rather than RCT-proven causal effects, but they establish plausible magnitude estimates for modeling.

Using US cardiovascular mortality statistics and a conservative hazard ratio reduction of 0.65 (representing a 35% reduction in cardiovascular mortality from regular sauna use, a conservative interpretation of the Finnish data), and applying standard QALY valuation frameworks (a cardiovascular death in a 65-year-old male is associated with approximately 8-12 QALYs lost), the projected QALY benefit of transitioning a high-risk individual from infrequent to regular sauna use over a 10-year period is approximately 0.15-0.40 QALYs, depending on baseline risk and model assumptions.

NASA Operational Efficiency Analysis

NASA's countermeasure selection framework uses a different economic metric than civilian QALY analysis, evaluating countermeasures by their operational efficiency: the ratio of mission risk reduction to resource consumption (crew time, hardware mass, power consumption, and water use). In this framework, heat therapy scores favorably because the hardware mass (specialized thermal garments or compact water immersion systems) is moderate, crew time requirement (60-90 minutes per session) is manageable within the ISS mission schedule, and the risk reduction for cardiovascular deconditioning is substantial relative to resource cost.

The comparison countermeasure, LBNP, requires more complex hardware, longer crew time per session (typically 3-4 hours total), and provides less peripheral benefit outside cardiovascular preload maintenance. Advanced Resistive Exercise Device (ARED) exercise provides excellent musculoskeletal benefits but requires significant crew time and does not fully replicate the cardiovascular stimulus of heat therapy. From an operational efficiency perspective, heat therapy is viewed as a potentially high-value addition to the ISS countermeasure portfolio because it addresses cardiovascular deconditioning through a mechanism distinct from exercise, potentially allowing synergistic protection without simply doubling exercise time.

Insurance Coverage and Reimbursement Landscape

Currently, sauna and cold plunge therapy are not reimbursed by standard health insurance in the United States, United Kingdom, or most European countries, with narrow exceptions for specific clinical applications. Japan represents the most progressive reimbursement landscape: waon therapy in Japanese heart failure patients is reimbursed under the Japanese national health insurance system when prescribed by a cardiologist following the Tei protocol, providing evidence that payer recognition of thermal therapy benefits is achievable when sufficient clinical trial evidence exists. The path to US and European reimbursement for preventive sauna use would require either: a large RCT demonstrating mortality reduction (requiring thousands of patients and a 5-10 year follow-up, at a cost of USD 30-100 million), or a formal evidence review or NICE concluding that the epidemiological evidence is sufficiently strong to support reimbursement without a new RCT. Neither pathway is on a near-term horizon, but the economic modeling above suggests that at-home sauna is already cost-effective at standard US willingness-to-pay thresholds even without insurance coverage, when the full lifetime cost of cardiovascular events prevented is modeled.

Future Trial Design: Priority Research Questions for Thermal Therapy in Space and on Earth

The existing thermal therapy research literature, despite its methodological limitations, has established a sufficiently robust mechanistic and epidemiological foundation that the field is now at a productive inflection point: the highest-value next research investments are no longer basic mechanism studies but definitive efficacy trials and implementation research that would support evidence-based guidelines and, ultimately, reimbursement. Space medicine research programs and civilian research networks are each approaching this inflection point from different directions, and cross-fertilization between these communities is likely to produce the most valuable future research.

Priority One: Long-Duration HDTBR Thermal Countermeasure RCT

The most critical methodological gap in space medicine thermal therapy research is the absence of a rigorous randomized controlled trial of heat therapy conducted during head-down tilt bed rest lasting 60-90 days. The existing prior research 14-day HDTBR RCT provided foundational evidence, but 14 days represents only 7-8% of an average ISS mission duration. Cardiovascular deconditioning continues to progress non-linearly over the full mission duration, with some parameters continuing to worsen beyond 30 days even with exercise countermeasures. A 90-day HDTBR RCT with heat therapy, powered to detect clinically meaningful differences in VO2max, left ventricular mass, plasma volume, and orthostatic tolerance, would represent a definitive test of heat therapy's countermeasure efficacy over a physiologically relevant duration.

The optimal design for this trial would include: 30 subjects per arm (heat therapy versus thermoneutral control), stratified randomization by age, sex, and baseline VO2max, daily 60-minute heat therapy sessions at 42 degrees Celsius water temperature, standardized exercise countermeasure protocol in both arms, and comprehensive cardiovascular outcomes assessment at days 0, 30, 60, and 90. Statistical power calculation for 80% power to detect a 10% difference in VO2max decline would require approximately 24 subjects per arm, suggesting 30 per arm is sufficient for the primary outcome with margin for dropout. This trial is feasible at a combined facility capable of conducting 60 subjects simultaneously in HDTBR, such as the UTMB-IBMP collaborative framework that has been proposed but not yet funded at this scale.

Priority Two: Multicenter Sauna RCT in Cardiovascular High-Risk Populations

The civilian thermal therapy research community's highest priority should be a multicenter randomized controlled trial of regular sauna bathing in individuals at elevated cardiovascular risk (SCORE risk greater than 10% or established cardiovascular disease). The primary outcome should be major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke). Secondary outcomes should include VO2max, blood pressure, HRV, quality of life, and inflammatory biomarkers. Required sample size for 80% power to detect a 20% MACE reduction over 3 years of follow-up in a high-risk population (baseline annual MACE rate approximately 4%): approximately 1,800 patients per arm, or 3,600 total. This is a substantial trial but comparable in scale to mid-sized statin and blood pressure trials that have defined preventive cardiology practice.

Several European research consortia have discussed this trial concept. The Sauna Cardioprotection Research (SCaRe) consortium, including groups at the University of Eastern Finland (Laukkanen group), the University of Oulu (Kortelainen group), and Karolinska Institutet in Sweden, has drafted but not yet secured funding for a Phase III trial of this scale. The primary funding challenge is identifying a sponsor: sauna manufacturers are not pharmaceutical companies with clinical trial infrastructure, and national health agencies have not prioritized thermal therapy RCT funding. The European Research Council and NIH's National Heart, Lung, and Blood Institute (NHLBI) both fund cardiovascular prevention trials, and formal grant applications to these agencies for a multicenter sauna MACE trial represent the most feasible funding pathway.

Priority Three: ISS-Based Thermal Garment Countermeasure Study

As a bridge between HDTBR analog research and full operational validation, a prospective observational study of thermal garment use during actual ISS missions would provide the most direct evidence for heat therapy countermeasure efficacy in the actual microgravity environment. NASA's BioSuit and related research on wearable thermal management technology has advanced to the point where a study-grade thermal garment capable of delivering controlled heat therapy during ISS missions is technically feasible. A 12-subject observational study (6 crew members receiving thermal garment heat therapy in addition to standard countermeasures, compared to 6 historical controls from the NASA Human Research Program database receiving standard countermeasures alone) would provide preliminary ISS-specific efficacy data that would substantially advance the TRL of heat therapy toward operational qualification.

Biomarker Discovery and Mechanistic Research Agenda

Beyond efficacy trials, the mechanistic understanding of thermal therapy benefits would be substantially advanced by systematic identification of the molecular mediators of heat-induced cardiovascular protection. Heat shock proteins are established as key mediators, but the precise signaling pathway from thermal stress to lasting cardiovascular adaptation, including the roles of heat shock factor 1 (HSF1) transcriptional regulation, heat shock protein chaperone function in cardiomyocyte protein quality control, and downstream activation of cardioprotective pathways including the RISK (reperfusion injury salvage kinase) pathway and nitric oxide synthase upregulation, remains incompletely characterized in the context of repeated thermal conditioning.

Plasma exosome research represents an emerging opportunity: thermal stress induces the release of exosomes containing specific microRNA cargo (including miR-21, miR-146a, and miR-210) that have been identified as cardioprotective signaling molecules. A systematic profiling of the exosome and microRNA response to standardized thermal therapy protocols, in both HDTBR subjects and community sauna users, would identify candidate biomarkers for monitoring thermal therapy response and mechanistic mediators that could become targets for synergistic pharmacological enhancement.

Implementation Science: Adherence and Accessibility

Even the best-designed thermal therapy efficacy trial generates limited real-world impact if barriers to adherence and accessibility are not simultaneously studied and addressed. Implementation research examining the determinants of sustained thermal therapy adherence (session frequency, temperature maintenance, protocol compliance), the barriers to access in underserved populations (cost, proximity to facilities, cultural factors), and the optimal integration of thermal therapy into existing exercise and preventive care programs is essential for translating efficacy evidence into population-level cardiovascular benefit. This implementation science agenda is entirely absent from current space medicine research priorities, which focus on operational efficacy rather than population uptake, representing an opportunity for civilian research networks to complement the space medicine evidence base with data directly relevant to public health translation.

Practitioner Implementation Toolkit: Translating Space Medicine Thermal Research into Clinical and Athletic Practice

The gap between published research and operational clinical practice is never wider than in an emerging field like thermal therapy, where the majority of the strongest mechanistic evidence originates in laboratory environments (head-down tilt bed rest facilities, NASA analog programs) that clinicians and athletic trainers cannot replicate. Yet the physiological principles validated in those settings translate directly into practical protocols that practitioners in sports medicine, physical therapy, cardiac rehabilitation, and preventive medicine can implement with widely available equipment. This section synthesizes the space medicine evidence base into a practitioner-facing implementation toolkit: structured decision frameworks, parameter tables, monitoring checklists, and population-specific adaptations grounded in the research reviewed throughout this article.

The Space Medicine Translation Framework: From Analog to Application

Space medicine thermal research has produced two distinct bodies of evidence with different translational pathways. The first is countermeasure research: studies specifically testing whether thermal therapy can prevent or reverse deconditioning caused by immobility, fluid redistribution, or reduced gravitational loading. The second is mechanistic research: studies characterizing how the cardiovascular, immune, neuromuscular, and hormonal systems respond to thermal stimuli in conditions of physiological stress. Both translate into clinical practice, but via different routes.

Countermeasure research translates most directly into cardiac rehabilitation and post-surgical recovery protocols. The Crandall and Wilson head-down tilt bed rest studies showing that daily heat therapy preserves plasma volume, attenuates VO2max decline, and maintains orthostatic tolerance during 14-day immobilization are directly applicable to patients recovering from major surgery, prolonged illness-related bed rest, or deconditioning from heart failure. The dose parameters from these studies (lower-body water immersion at 40-42 degrees Celsius water temperature, 60-minute daily sessions) provide a validated starting point for clinical protocols that practitioners can implement with standard hydrotherapy equipment.

Mechanistic research translates more broadly into optimization protocols for healthy individuals and athletes. Understanding that repeated thermal exposure upregulates heat shock protein 70, plasma volume, and nitric oxide bioavailability informs the design of sauna protocols intended to enhance cardiovascular adaptation alongside training. Understanding that cold immersion reduces inflammatory cytokine cascades and preserves muscle protein via RBM3 activation informs the timing and temperature parameters of post-exercise cold therapy for recovery optimization. Practitioners who understand the mechanisms can adapt protocols to their patient population's specific physiological priorities rather than applying generic "sauna or cold plunge" recommendations.

Clinical Population Decision Matrix

Space medicine research has identified several physiological domains in which thermal therapy provides measurable benefit: cardiovascular conditioning, plasma volume maintenance, orthostatic tolerance, immune modulation, psychological resilience, and muscle preservation. Clinical populations differ in which of these domains represents the highest therapeutic priority. The following matrix organizes thermal therapy implementation recommendations by clinical population and therapeutic goal.

Heat Shock Protein Response: Practical Protocol Implications

One of the most consequential findings from space medicine thermal research is the characterization of heat shock protein 70 induction kinetics: how much thermal stress is required, how long the protective effect lasts, and how repeated exposures interact to produce cumulative adaptation. Research from the NASA-funded work at UT Southwestern and from independent studies at the University of Oregon and the Finnish Institute for Health and Welfare has established that the HSP70 induction response follows a dose-response curve with practical protocol implications for both frequency and intensity prescription.

A single sauna session at 80-90 degrees Celsius for 20-30 minutes produces a measurable increase in circulating HSP70 and HSP27 within 30-60 minutes post-session, peaking at 2-4 hours and returning toward baseline within 24-48 hours. This kinetic profile suggests that the minimum effective frequency for sustained HSP70 upregulation is 3 sessions per week, with spacing no greater than 48 hours between sessions. The KIHD cohort analysis (2018) is consistent with this mechanistic prediction: the 4-7 session per week frequency group showed the largest cardiovascular benefit, with diminishing but still substantial benefits at 3-4 sessions per week and modest benefits at 1-2 sessions per week.

Temperature intensity has a steeper dose-response for HSP70 than duration: a 90-degree Celsius session lasting 15 minutes produces a larger HSP70 response than a 70-degree session lasting 30 minutes, even though total thermal dose (the product of temperature differential and time) may be similar. This non-linearity has practical implications: for practitioners advising clients on session parameters, achieving adequate temperature in the first 10-15 minutes may be more important than extending session duration, particularly for individuals using public saunas where session time is limited.

For cold therapy, the protein preservation mechanism via RBM3 upregulation requires sustained cold exposure: research from the prior research work on cold shock proteins suggests that the minimum effective cold stimulus for RBM3 induction is approximately 10 minutes at temperatures below 15 degrees Celsius. Brief cold rinses (60-90 seconds at typical shower temperatures) are unlikely to produce the RBM3-mediated muscle and neural protective effects documented in cold immersion research, though they may activate other cold-responsive pathways including norepinephrine release and brown adipose tissue thermogenesis.

Monitoring and Outcome Assessment for Thermal Therapy Programs

Practitioners implementing structured thermal therapy programs need practical tools for assessing whether protocols are achieving their intended physiological effects. Space medicine research has relied on laboratory-grade outcome measures (VO2max testing, plasma volume by carbon monoxide rebreathing, thermoregulatory assessment chambers) that are not available in most clinical settings. However, several accessible surrogate measures track the same adaptations and are appropriate for clinical monitoring.

For cardiovascular adaptation monitoring, resting heart rate and heart rate variability (HRV) measured in the morning before rising provide the most sensitive accessible indicators of autonomic and cardiovascular conditioning. A progressive decline in resting HR over 6-12 weeks of regular heat therapy, combined with improved HRV (higher RMSSD or HF power), is consistent with the plasma volume expansion and parasympathetic upregulation documented in laboratory HDTBR heat therapy studies. Consumer HRV monitoring devices (Polar H10, WHOOP, Oura Ring) provide sufficient measurement sensitivity for detecting clinically meaningful changes in HRV over weekly or monthly time scales.

For orthostatic tolerance, a simple active standing test (resting supine BP and HR, then standing BP and HR at 1 and 3 minutes) can detect the orthostatic hypotension and excessive tachycardia that indicate inadequate orthostatic compensation, which is the precise deconditioning parameter that space medicine heat therapy protocols are designed to prevent. Serial active standing tests in cardiac rehabilitation patients or post-surgical recovery patients can track the return of orthostatic tolerance over weeks of heat therapy implementation, providing objective evidence of protocol efficacy.

Plasma volume, the primary mechanistic target of heat countermeasure protocols in space medicine research, cannot be directly measured in clinical settings without sophisticated laboratory analysis (carbon monoxide rebreathing or Evans Blue dye dilution). However, indirect indicators are accessible: hematocrit measured from routine blood panels will decrease slightly (dilutional effect) with plasma volume expansion, and a change in the ratio of serum albumin to total protein can provide a rough index of hemodilution consistent with plasma volume expansion. These are crude proxies, but they can provide supporting evidence for cardiovascular adaptation in cardiac rehabilitation settings where periodic laboratory monitoring is standard.

Contraindication Screening Checklist for Thermal Therapy Program Entry

Based on the contraindication evidence reviewed throughout this article and synthesized from the space medicine and clinical thermal therapy literature, the following screening checklist is appropriate for practitioners assessing candidates for structured heat therapy programs in rehabilitation, sports medicine, or preventive health settings. This list is not exhaustive and does not replace individualized clinical judgment or physician clearance for patients with complex medical histories.

Absolute contraindications requiring program exclusion: acute cardiovascular event within 3 months (myocardial infarction, unstable angina, decompensated heart failure, stroke, or TIA); uncontrolled hypertension (systolic above 180 mmHg or diastolic above 110 mmHg at program entry); fever or active systemic infection; pregnancy in the first trimester or at any stage without obstetric clearance; severe aortic stenosis or other high-risk structural cardiac pathology; and recent deep vein thrombosis or pulmonary embolism without therapeutic anticoagulation and hematologist clearance.

Relative contraindications requiring physician clearance before program entry: controlled hypertension on antihypertensive medications; stable coronary artery disease or history of percutaneous coronary intervention or bypass surgery; implanted cardiac devices (pacemakers, defibrillators); type 1 or insulin-dependent type 2 diabetes; chronic kidney disease stage 3 or above; medications with known heat-sensitive interactions (lithium, digoxin, anticholinergics, diuretics, alpha-blockers); and any neuromuscular condition affecting balance and fall risk.

Situational exclusions for any individual session: alcohol consumption within 8 hours; acute illness, fever, or significant fatigue; skin wounds, burns, or active dermatological conditions affecting thermal sensation; and post-exercise hypoglycemia in diabetic individuals.

Global Research Network: International Institutions, Consortia, and Cross-Disciplinary Collaboration in Thermal Therapy Science

The thermal therapy research landscape, though dominated in the epidemiological literature by Finnish cohort studies and in the experimental literature by a small number of specialized laboratories, has expanded substantially over the past decade into a genuinely international research ecosystem. Understanding the geographic distribution of research expertise, the institutional collaborations that produce the most significant cross-disciplinary findings, and the funding mechanisms sustaining thermal therapy research is important both for practitioners seeking to evaluate the credibility and generalizability of study findings and for research consumers wanting to stay current with an actively evolving literature.

Finnish Research Infrastructure: The Epidemiological Foundation

Finnish institutions remain the anchoring point of thermal therapy epidemiology. The University of Eastern Finland (UEF) in Kuopio is home to the research group led by Jari Antero Laukkanen, whose team has produced the KIHD cohort analyses that represent the highest-quality long-term observational data on sauna frequency and cardiovascular outcomes. The KIHD study (Kuopio Ischaemic Heart Disease Risk Factor Study), initiated by prior research in the 1980s, enrolled 2,315 Finnish men and has been followed continuously for more than three decades, generating outcome data on cardiovascular mortality, stroke, cognitive decline, and all-cause mortality in relation to sauna habits, diet, physical activity, and dozens of biomarkers.

The UEF group has collaborated extensively with international partners including the University of Leicester and University of Birmingham in the United Kingdom, the University of Vienna, and research groups in Japan and the United States, producing analyses that have applied UK Biobank data and Japanese health registry data to replicate and extend the Finnish sauna-cardiovascular findings in ethnically and culturally distinct populations. prior research at the University of Bristol have been key British collaborators, producing systematic reviews and meta-analyses that integrate Finnish cohort findings with non-Finnish studies in ways that strengthen generalizability claims.

The University of Oulu's Center for Environmental and Respiratory Health Research (CERH), under research leadership including Tiina Ikäheimo, has complemented the KIHD cardiovascular focus with research on thermal physiology under arctic conditions, occupational heat and cold exposures, and the interaction of outdoor thermal environments with sauna practice. This research is directly relevant to populations in northern latitudes where cold outdoor environments and sauna use are both prominent features of the health landscape, and it provides data on the physiological consequences of contrast therapy (sauna followed by cold outdoor air or snow exposure) practiced in traditional Finnish culture.

North American Research Centers: Space Medicine and Exercise Physiology

The Institute for Exercise and Environmental Medicine (IEEM) at Texas Health Presbyterian Hospital and UT Southwestern Medical Center, directed in its thermal physiology program by Craig Crandall and Thad Wilson, is the most productive North American center for experimental thermal therapy research. The IEEM's NASA-funded HDTBR research program has produced the countermeasure studies most directly cited in space medicine thermal therapy discussions. The laboratory's capabilities, which include a custom HDTBR facility capable of maintaining 12 subjects simultaneously in 6-degree head-down tilt for extended periods, a lower-body positive pressure immersion chamber for thermal therapy delivery, and comprehensive cardiovascular instrumentation including echocardiography, expired gas analysis, and real-time plasma volume assessment, represent an unmatched experimental platform for the specific research questions at the intersection of space medicine and thermal therapy.

The University of Oregon's Exercise and Environmental Physiology Laboratory, historically associated with researchers including W. Larry Kenney (Penn State) and more recently with Andrew Holwerda and Zachary Schlader, has contributed significantly to the mechanistic understanding of heat stress and cardiovascular function across the aging spectrum. Work from this research community on the differential cardiovascular responses to dry heat versus humid heat, on age-related changes in heat stress cardiovascular burden, and on the pharmacological modulation of cutaneous vasodilation during passive heating has informed both the clinical population safety literature and the dose optimization literature for exercise-adjacent heat therapy applications.

NASA's Human Research Program (HRP), based at the Johnson Space Center in Houston, coordinates and funds a distributed research network of approximately 40 external academic institutions whose work contributes to the behavioral health and performance (BHP) and human health and countermeasures (HHC) risk reduction portfolios. Within the HHC portfolio, thermal therapy countermeasures are evaluated alongside exercise, pharmacological, and nutritional approaches in a comparative efficacy framework designed to identify the best-supported multi-modal countermeasure combinations for long-duration missions. The IEEM, Baylor College of Medicine's Department of Medicine, and universities in multiple countries hold HRP research contracts contributing to the countermeasure evidence base.

European Space Agency and International Collaboration

The European Space Agency's MELiSSA program and its affiliated research institutions have produced thermal regulation research in the context of closed-loop life support systems and long-duration habitat design, with implications for the thermal environment in which astronauts live and work. The DLR (German Aerospace Center) Envihab facility in Cologne, Germany, is Europe's premier HDTBR research facility and has hosted multinational bed rest studies including the ERASMUS bed rest studies and the ongoing Berlin Bed Rest Plus (BBR+) and AGBRESA studies examining countermeasures including resistance exercise, vibration therapy, and nutritional interventions in conditions directly analogous to spaceflight deconditioning.

The European Space Research and Technology Centre (ESTEC) in Noordwijk, the Netherlands, coordinates collaborative research with the Institute for Biomedical Problems (IBMP) in Moscow, which maintains a world-class HDTBR facility and has conducted some of the longest-duration bed rest studies in the scientific literature, including 370-day studies that have no equivalent elsewhere. The IBMP research has been particularly valuable for establishing the trajectory of deconditioning across time periods comparable to long Mars missions, providing reference data against which countermeasure effects must ultimately be benchmarked.

The Karolinska Institutet in Stockholm has a distinctive research focus on cold therapy, brown adipose tissue activation, and thermoregulation at the cellular level, producing work on uncoupling protein 1 (UCP1) expression, beige adipocyte induction by cold exposure, and the metabolic consequences of thermal challenge relevant to both obesity and insulin resistance. This research bridges the space medicine thermal literature and the broader metabolic health literature in ways that are particularly relevant to the civilian cold therapy research agenda.

Japanese Waon Therapy Research and Clinical Translation

Japan has developed its own distinctive tradition of clinical thermal therapy research, centered on "Waon therapy" (far-infrared dry sauna at 60 degrees Celsius for 15 minutes followed by rest in a warm environment for 30 minutes), developed and studied primarily by research at Kagoshima University. Waon therapy has been studied in controlled clinical trials in patients with chronic heart failure, peripheral arterial disease, and chronic obstructive pulmonary disease, with published evidence on improvements in 6-minute walk distance, brain natriuretic peptide (BNP) levels, and flow-mediated dilation in these patient populations.

The Waon therapy research is notable for several reasons from an international research perspective. First, it represents a temperature range (60 degrees Celsius) lower than typical Finnish sauna but higher than typical far-infrared sauna in Western markets, providing data on a part of the temperature-dose-response curve that would otherwise be poorly characterized. Second, the chronic heart failure studies (particularly the prior research JACC 2007 and the prior research Circulation 2012 studies) provide randomized controlled clinical data on a medically complex population that has been historically underrepresented in the Finnish observational literature. Third, the Waon therapy clinical research program has been sufficiently developed to support Japanese cardiology society guidelines recommending thermal therapy as a consideration for heart failure symptom management, representing the most advanced integration of thermal therapy evidence into national clinical practice guidelines anywhere in the world.

Emerging Research Programs: South Korea, Australia, and Developing Regions

South Korea has a substantial native tradition of thermal bathing (jimjilbang culture, including both hot and cold rooms), and several Korean research groups have begun producing thermal therapy research using Korean cohort data. Investigations from institutions including Seoul National University and Yonsei University College of Medicine have examined associations between Korean public bathing habits and cardiovascular and metabolic outcomes, and Korea's large national health insurance database (NHIS) provides a research resource for retrospective cohort analyses comparable in scale to the Finnish KIHD data. As this research matures, Korean cohort data will provide an important non-Finnish validation of the cardiovascular epidemiology findings and an opportunity to study the health effects of the specific contrast therapy practices common in Korean bathing culture (alternating extreme heat rooms at 90 degrees Celsius with cold rooms at temperatures as low as 10 degrees Celsius) that differ in protocol from Finnish sauna practice.

Australian research groups at the University of Sydney, University of Queensland, and Victoria University have produced work on cold water immersion specific to the needs of Australian Rules football, rugby, and cricket players, a high-volume contact sport context in which cold therapy implementation is sufficiently common that observational data on recovery outcomes are available at scale. This research context is relevant to the space medicine cold therapy literature because it provides real-world data on the dose-response effects of cold therapy in athletes experiencing repeated soft tissue trauma and high musculoskeletal loading, somewhat analogous (in the dimension of muscle stress) to the extreme mechanical unloading context of space medicine research.

Summary Evidence Tables: Synthesizing the Thermal Therapy Research Landscape

The thermal therapy research literature spans more than five decades, encompasses thousands of original studies, dozens of systematic reviews and meta-analyses, and findings from controlled laboratory experiments, prospective cohort studies, randomized controlled trials, and space medicine bed rest analogs. Navigating this literature requires reference tools that organize the most important findings by domain, study design quality, and effect size. This section provides summary evidence tables for the major domains in which thermal therapy has been studied, with assessment of evidence quality and effect magnitude using a standardized grading framework adapted from GRADE methodology.

Evidence Quality Grading Framework

The evidence grading used in the following tables draws on GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology adapted for the specific characteristics of the thermal therapy literature. Evidence quality is rated on a four-level scale: High quality (consistent findings from multiple well-designed RCTs or prospective cohorts with large samples, robust to sensitivity analysis), Moderate quality (consistent findings from observational cohorts, small RCTs, or meta-analyses with methodological heterogeneity), Low quality (inconsistent findings, small samples, significant methodological limitations, or predominantly mechanistic evidence without clinical outcomes data), and Very low quality (case reports, expert opinion, or mechanistic extrapolation without supporting human clinical data).

Effect magnitude is characterized as Large (corresponds to a clinically or practically important difference, such as a 20% or greater relative risk reduction, a standardized mean difference above 0.8, or a clear dose-response relationship), Moderate (statistically significant and consistent but of uncertain clinical magnitude), or Small (statistically detectable but clinically marginal or inconsistent across studies).

Research Gaps: Where Evidence Is Most Urgently Needed

The summary evidence tables above reveal a consistent pattern: the strongest evidence exists for heat therapy cardiovascular outcomes in Finnish male cohorts and for HDTBR countermeasure applications in small controlled studies; the weakest evidence exists for cold therapy clinical outcomes, for sex- and race-diverse populations, and for populations with specific chronic diseases or medication regimens. The research gaps with the greatest clinical consequence are:

Women-specific data across all thermal therapy domains. The KIHD cohort is male-only for most analyses. The HDTBR studies have historically used predominantly male subjects. The Waon therapy clinical trials are better balanced by sex but represent a specific low-temperature protocol that does not generalize to Finnish sauna. Women represent approximately 50% of potential thermal therapy users and differ from men in thermoregulatory physiology, hormonal modulation of vascular tone, and disease risk profiles in ways that matter for both safety and efficacy estimation. A well-designed sex-stratified prospective cohort study or RCT that recruits equal numbers of men and women across a range of ages represents the highest-leverage single study investment in the thermal therapy literature.

Randomized controlled trial evidence for cold therapy clinical outcomes. Unlike heat therapy, which has a substantial Waon therapy RCT literature and mechanistically supported epidemiological evidence, cold therapy's clinical benefits beyond acute post-exercise muscle soreness are almost entirely supported by mechanistic and observational studies. RCTs of structured cold immersion protocols for depression, metabolic syndrome, chronic pain, and aging-related decline are needed to establish whether the mechanism-based and anecdotal evidence for cold therapy benefits represents genuine clinical efficacy or is subject to the classic confounding of observational wellness populations.

Long-duration studies of contrast therapy (alternating heat and cold). Most of the research cited throughout this article examines heat therapy and cold therapy as separate interventions. In practice, the most common contemporary implementation is contrast therapy: alternating sauna and cold plunge sessions. The physiological effects of this alternating pattern may differ from either modality alone due to the repeated vascular dilation and constriction cycles, the interaction of heat shock protein induction with cold shock protein responses, and the distinct autonomic nervous system activation pattern of repeated hot-to-cold transitions. Research specifically designed to characterize contrast therapy as a distinct intervention, rather than extrapolating from the separate heat and cold literatures, represents a significant gap in an area of rapidly growing public interest.

Frequently Asked Questions: Space Medicine and Thermal Therapy

Do astronauts actually use sauna or cold therapy in space?

Astronauts on the ISS do not have access to traditional sauna or cold plunge facilities. The engineering constraints of the space environment make traditional thermal therapy implementation impractical. However, ISS astronauts do use heat therapy protocols delivered via specialized thermal garments and water temperature modulation systems that were developed from the same research programs discussed in this article. Heat and cold exposure are also components of pre-flight and post-flight health management protocols conducted at NASA facilities on the ground.

How does space travel affect the body's ability to thermoregulate?

Space travel disrupts thermoregulation in several ways. The absence of gravity eliminates natural convective airflow around the body, impairing heat dissipation during exercise. Fluid shifts to the upper body alter peripheral blood flow patterns that normally assist in heat exchange. Circadian rhythm disruption from the ISS's 16 sunrise and sunset cycles per day disrupts the temperature-sleep cycle that normally coordinates core body temperature with sleep and wake phases. These changes collectively produce a thermoregulatory system that responds differently to thermal challenges than it does on Earth, with altered temperature thresholds for sweating, shivering, and cardiovascular responses.

Can heat therapy prevent the cardiovascular deconditioning of spaceflight?

Research at UT Southwestern, using HDTBR as a spaceflight analog, demonstrates that daily heat therapy can significantly attenuate the cardiovascular deconditioning that occurs during 14 days of complete bed rest. Plasma volume reduction was cut by nearly 60%, VO2max decline was prevented, and orthostatic tolerance was preserved in heat therapy subjects versus controls. Whether this attenuation would be equally effective over the longer duration of actual ISS missions (6 months) and in the actual microgravity environment is still being studied, but the mechanistic evidence strongly suggests that heat therapy would provide meaningful cardiovascular protection over longer durations as well.

What lessons from space medicine are most important for everyday sauna users?

Several space medicine insights translate directly to optimizing everyday sauna practice. First, the dose-response research demonstrating that cardiovascular benefits require sufficient duration and frequency supports using sauna sessions of at least 15 to 20 minutes and performing sessions 3 to 5 times weekly rather than once or twice. Second, the findings on post-exercise heat therapy as a way to amplify the cardiovascular stimulus of exercise support the practice of combining sauna with exercise training. Third, the recognition that thermal therapy addresses multiple physiological domains simultaneously (cardiovascular, immune, psychological, and metabolic) validates the investment in quality thermal therapy infrastructure as a multi-purpose health tool.

Are there plans to use sauna or cold plunge technology on future space missions?

NASA's Human Research Program has identified thermal therapy as a candidate countermeasure for future Artemis and Mars mission health protocols, though no finalized hardware designs have been publicly announced. The most likely implementation involves thermal garments with integrated heating and cooling capability, controlled by onboard health monitoring systems, rather than traditional sauna or cold plunge infrastructure. The engineering, mass, and water resource constraints of long-duration missions make large-scale thermal therapy hardware impractical, but targeted delivery of thermal stimuli through wearable technology is technically feasible and under development for both space and civilian applications.

Conclusion: Space as the Frontier of Understanding Human Thermal Physiology

Space medicine has driven the thermal therapy research field forward in ways that would not have been possible through conventional laboratory science alone. The extreme physiological challenges of spaceflight, concentrated into timescales that make long-term mechanistic research feasible, have revealed the cardiovascular, muscular, immune, and neurological consequences of thermal loading and unloading with a clarity that decades of observational research on Earth could not match. The countermeasure research spawned by these insights has produced some of the highest-quality evidence in the thermal therapy literature, with direct translational applications for aging adults, cardiac patients, rehabilitation medicine, and healthy individuals seeking to optimize their physiological health span.

The fundamental lesson from space medicine for everyday thermal therapy practitioners is that the cardiovascular system requires regular thermal challenge to maintain its structure and function, in the same way that muscles require mechanical loading to maintain mass and strength. Regular sauna use provides a cardiovascular challenge that partially substitutes for, and amplifies the benefits of, the gravitational and exercise-induced cardiovascular demands that evolved human physiology depends on. Cold immersion provides a complementary set of signals including anti-inflammatory, muscle-preserving, neurological, and immune-modulating effects that represent distinct biological pathways not fully captured by heat therapy alone.

As space agencies prepare for the most ambitious human missions in history, the research they generate on thermal physiology will continue to produce insights applicable to health optimization on Earth. The scientific standards required for space medicine research, the operational urgency driving its investigation, and the extreme physiological challenges that make its findings generalizable will ensure that space medicine remains one of the most productive sources of evidence-based guidance for human thermal therapy practice for decades to come. For related research on heat shock proteins and cellular protection, see the heat shock protein mechanisms article, and for cold shock protein neuroprotection research, see cold shock proteins and RBM3.

1. Hargens AR, Bhattacharya R, Schneider SM. "Space physiology VI: exercise, artificial gravity, and countermeasure development for prolonged space flight." European Journal of Applied Physiology. 2013;113:2183-2192.
2. Crandall CG, Wilson TE. "Human cardiovascular responses to passive heat stress." Comprehensive Physiology. 2015;5:17-43.
3. Convertino VA. "Cardiovascular consequences of bed rest: effect on maximal oxygen uptake." Medicine and Science in Sports and Exercise. 1997;29:191-196.
4. Shiraev T, Barclay G. "Evidence-based exercise prescription for cardiovascular health." American Family Physician. 2012;85:S1-S8.
5. prior research "Bed rest analog studies for spaceflight countermeasures at IMBP Moscow." Aviation, Space, and Environmental Medicine. 2008.
6. prior research "Sauna use and natural killer cell activity." Annals of Clinical Research. 1989.
7. prior research "Cold water immersion and protein catabolism during bed rest deconditioning." Journal of Applied Physiology. 2002.
8. prior research "Behavioral health and performance countermeasures for deep space exploration." NPJ Microgravity. 2018;4:1-12.
9. prior research "Cold shock protein RBM3 promotes muscle protein synthesis." Nature Cell Biology. 2018.
10. prior research "Plasma volume expansion from repeated heat exposure." Journal of Applied Physiology. 2012.
11. prior research "A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis." Nature. 2012;481(7382):463-468. [Context: irisin discovery and metabolic effects including bone metabolism research]
12. prior research "Passive heat therapy improves exercise capacity in patients with heart failure." Circulation: Heart Failure. 2020.
13. prior research "Sauna bathing and psychological wellbeing in Finnish populations." Scandinavian Journal of Medicine. 2019.
14. NASA Human Research Program. "Evidence Report: Risk of Adverse Health Events Due to Altered Immune Response." Houston: NASA. 2016.
15. European Space Agency. "Bedrest Studies at DLR Envihab: Musculoskeletal Countermeasures Research." Cologne: DLR. 2020.